| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | CDK9 NCOA3 NCOA6 CAND2 DTX3L ZFPM1 HIRA MED24 HCFC2 ANKRD42 CRTC3 RARA RARB PCLO KAT6A SIX1 SIX3 CCNT1 NCOR2 ARNT RNF6 MTOR BBS7 EHMT1 LRP2 SPEN CNOT1 | 1.39e-07 | 753 | 227 | 27 | GO:0008134 |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (acetyl-transferring) kinase activity | 1.43e-05 | 5 | 227 | 3 | GO:0004740 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NCOA3 NCOA6 ZFPM1 SSX5 DDX1 HIRA MED24 HCFC2 NOTCH1 IL31RA TCF20 KAT6A SIRT6 NCOR2 KMT2D MAML2 SPEN | 8.12e-05 | 562 | 227 | 18 | GO:0003712 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA3 NCOA6 DTX3L ZFPM1 HIRA MED24 ANKRD42 RARB NCOR2 ARNT RNF6 BBS7 LRP2 SPEN CNOT1 | 9.11e-05 | 417 | 227 | 15 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA3 NCOA6 DTX3L ZFPM1 HIRA MED24 ANKRD42 CRTC3 RARB KAT6A CCNT1 NCOR2 ARNT RNF6 BBS7 LRP2 SPEN CNOT1 | 1.26e-04 | 582 | 227 | 18 | GO:0140297 |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase (ATP) activity | 1.29e-04 | 2 | 227 | 2 | GO:0004781 | |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase activity | 1.29e-04 | 2 | 227 | 2 | GO:0004779 | |
| GeneOntologyMolecularFunction | adenylylsulfate kinase activity | 1.29e-04 | 2 | 227 | 2 | GO:0004020 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA3 NCOA6 ILK MYO1D FZD1 AP2M1 PTPN12 NOD1 UBR5 DMD TACC3 DNM2 CABP1 MICAL1 RARA POU2F2 MTOR TP63 EHMT1 LRP2 CTNND1 CNOT1 MYB | 1.69e-04 | 875 | 227 | 23 | GO:0019904 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA3 NCOA6 DTX3L ZFPM1 ZZEF1 SSX5 DDX1 HIRA MED24 MAGI2 AP2M1 HCFC2 NOTCH1 CUL1 IL31RA SH3RF1 TCF20 KAT6A GRB10 AMBRA1 SIRT6 CCNT1 NCOR2 KMT2D MAML2 SPEN | 3.27e-04 | 1160 | 227 | 27 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA3 NCOA6 DTX3L ZFPM1 ZZEF1 SSX5 DDX1 HIRA MED24 MAGI2 AP2M1 HCFC2 NOTCH1 CUL1 IL31RA SH3RF1 TCF20 KAT6A GRB10 AMBRA1 SIRT6 LDLR CCNT1 NCOR2 KMT2D GIGYF2 MAML2 SPEN CNOT1 | 3.55e-04 | 1356 | 227 | 30 | GO:0060090 |
| GeneOntologyMolecularFunction | type II activin receptor binding | 3.83e-04 | 3 | 227 | 2 | GO:0070699 | |
| GeneOntologyMolecularFunction | ubiquitin-ubiquitin ligase activity | 4.81e-04 | 14 | 227 | 3 | GO:0034450 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | UBE4B MYCBP2 PEX12 DTX3L ZZEF1 MED24 ZNRF3 UBR5 CUL1 SH3RF1 PELI1 TRIM33 RNF6 | 6.66e-04 | 398 | 227 | 13 | GO:0061659 |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA3 NCOA6 MED24 HCFC2 NOTCH1 IL31RA TCF20 KAT6A KMT2D MAML2 | 7.31e-04 | 303 | 227 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | poly-purine tract binding | 8.00e-04 | 37 | 227 | 4 | GO:0070717 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | UBE4B MYCBP2 PEX12 DTX3L MED24 ZNRF3 UBR5 CUL1 SH3RF1 PELI1 TRIM33 RNF6 | 1.19e-03 | 372 | 227 | 12 | GO:0061630 |
| GeneOntologyMolecularFunction | histone modifying activity | 1.27e-03 | 229 | 227 | 9 | GO:0140993 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | NCOA3 INTU ILK SLC39A1 UBE4B INHBA PSG6 ESRP1 ZFAND5 ZFPM1 MKS1 FZD1 MET BMP6 NF1 ALMS1 TRPM1 SLITRK6 KDM6A NOTCH1 CUL1 RARA RARB KAT6A LAMA5 SIRT6 SIX1 SIX3 ZIC1 NCOR2 MTOR BBS7 TP63 LRP2 CTNND1 EPHB1 | 1.58e-07 | 1269 | 227 | 36 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 NCOA6 INTU SLC39A1 INHBA ZFAND5 ZFPM1 MKS1 HIRA FZD1 NF1 MCRS1 LRRC7 SLITRK6 KDM6A NOTCH1 RARA RARB KAT6A AFF3 LAMA5 AMBRA1 SIX1 SIX3 THOC5 ZIC1 NCOR2 FOXD3 ARNT KMT2D UTP25 BBS7 TP63 EHMT1 LRP2 CNOT1 MYB | 1.11e-06 | 1437 | 227 | 37 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic organ development | NCOA3 NCOA6 SLC39A1 ZFPM1 MKS1 SLITRK6 KDM6A NOTCH1 RARA RARB KAT6A SIX1 SIX3 THOC5 ZIC1 FOXD3 ARNT UTP25 BBS7 MYB | 4.32e-06 | 561 | 227 | 20 | GO:0048568 |
| GeneOntologyBiologicalProcess | regulation of acetyl-CoA biosynthetic process from pyruvate | 5.22e-06 | 4 | 227 | 3 | GO:0010510 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CDK9 BCL9L NCOA3 NCOA6 ERG INHBA ECD ZFPM1 MED24 MET BMP6 UBP1 MCRS1 MGA KDM6A PHIP NOTCH1 HJV CRTC3 RARA RARB TCF20 POU2F2 SIX1 SIX3 ZIC1 CCNT1 FOXD3 ARNT KMT2D TP63 PAXIP1 MAML2 MYB | 9.67e-06 | 1390 | 227 | 34 | GO:0045944 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | NCOA3 INTU ILK UBE4B INHBA ESRP1 ZFPM1 MKS1 FZD1 MET ALMS1 KDM6A NOTCH1 RARA LAMA5 SIRT6 SIX1 SIX3 MTOR BBS7 TP63 LRP2 CTNND1 | 9.74e-06 | 750 | 227 | 23 | GO:0048729 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | ILK ZZEF1 NF1 TACC3 NOTCH1 WDR62 RARB SIX3 KIFAP3 NCOR2 LRP2 EPHB1 | 1.12e-05 | 233 | 227 | 12 | GO:0061351 |
| GeneOntologyBiologicalProcess | heart development | NCOA6 ILK UBE4B INHBA RPS6KA2 ZFPM1 MKS1 FZD1 MET NF1 PDLIM3 KDM6A NOTCH1 DNM2 RARA RARB KAT6A SIRT6 SIX1 NCOR2 MTOR BBS7 LRP2 | 1.13e-05 | 757 | 227 | 23 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of acyl-CoA biosynthetic process | 1.29e-05 | 5 | 227 | 3 | GO:0050812 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | NCOA3 INHBA PSG6 ZFPM1 NF1 ZNF608 DMD NOTCH1 CNTN2 FNDC3B RARA RARB TNFSF18 BICRA SIX3 LDLR THOC5 KIFAP3 NCOR2 RNF6 TP63 BICRAL IL17RD MYB EPHB1 | 1.32e-05 | 875 | 227 | 25 | GO:0045596 |
| GeneOntologyBiologicalProcess | heart morphogenesis | ILK UBE4B ZFPM1 MKS1 FZD1 KDM6A NOTCH1 KAT6A SIRT6 SIX1 NCOR2 MTOR BBS7 LRP2 | 1.38e-05 | 321 | 227 | 14 | GO:0003007 |
| GeneOntologyBiologicalProcess | maintenance of cell number | BCL9L NCOA3 WDR43 MED24 WDR62 BICRA KAT6A SIRT6 ZIC1 TP63 BICRAL CNOT1 | 1.63e-05 | 242 | 227 | 12 | GO:0098727 |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.43e-05 | 78 | 227 | 7 | GO:2000036 | |
| GeneOntologyBiologicalProcess | limb development | 4.03e-05 | 224 | 227 | 11 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.03e-05 | 224 | 227 | 11 | GO:0048736 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | DTX3L NF1 UBR5 MCRS1 PHIP NOTCH1 CABP1 CCT2 SIRT6 SIX1 SIX3 ZIC1 UTP25 MTOR | 5.18e-05 | 362 | 227 | 14 | GO:0034504 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | NCOA3 INTU ILK ESRP1 MKS1 FZD1 MET ALMS1 KDM6A NOTCH1 RARA LAMA5 SIRT6 SIX1 MTOR BBS7 TP63 LRP2 CTNND1 | 5.90e-05 | 619 | 227 | 19 | GO:0002009 |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | NCOA3 PDK3 NOD1 UBR5 HCFC2 RARA RARB NLRX1 PELI1 NCOR2 ARNT KMT2D RNF6 TP63 CNOT1 | 6.20e-05 | 416 | 227 | 15 | GO:0030522 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | ILK MYO5B MET NF1 FIG4 SLITRK6 NOTCH1 WDR62 RARA RARB ADGRL1 LDLR KIFAP3 RNF6 MTOR LRP2 SPEN MYB EPHB1 | 6.70e-05 | 625 | 227 | 19 | GO:0051960 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | BCL9L NCOA3 WDR43 MED24 WDR62 BICRA KAT6A SIRT6 TP63 BICRAL CNOT1 | 6.71e-05 | 237 | 227 | 11 | GO:0019827 |
| GeneOntologyBiologicalProcess | epithelium development | NCOA3 INTU ILK INHBA PSG6 ESRP1 MKS1 FZD1 MAGI2 MET BMP6 NF1 ALMS1 CCDC78 DMD SLITRK6 KDM6A NOTCH1 FNDC3B IL31RA RARA RARB LAMA5 AMBRA1 SIRT6 SIX1 SIX3 NCOR2 MTOR BBS7 TP63 LRP2 CTNND1 | 7.18e-05 | 1469 | 227 | 33 | GO:0060429 |
| GeneOntologyBiologicalProcess | muscle structure development | CDK9 BCL9L ILK UBE4B ZFPM1 HIRA FZD1 DOCK5 MET NF1 PDLIM3 DMD NOTCH1 RARA RARB LAMA5 SIRT6 SIX1 MTOR WFIKKN2 LRP2 VPS13B EPHB1 | 7.87e-05 | 858 | 227 | 23 | GO:0061061 |
| GeneOntologyBiologicalProcess | neuron projection development | ILK MYO5B UBE4B MYCBP2 CYTH2 TENM2 MKS1 FZD1 MAGI2 MET NF1 HMCN2 ALMS1 FIG4 LRRC7 KIF3C DMD SLITRK6 NOTCH1 CNTN2 MOV10 DNM2 LAMA5 FRYL CELSR3 RNF6 MTOR LRP2 VPS13B EPHB1 | 8.00e-05 | 1285 | 227 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 8.45e-05 | 202 | 227 | 10 | GO:0141193 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | NCOA3 ALMS1 DMD SLITRK6 KDM6A RARA RARB SIX3 MTOR GIGYF2 VPS13B | 1.04e-04 | 249 | 227 | 11 | GO:0035264 |
| GeneOntologyBiologicalProcess | muscle organ development | BCL9L UBE4B ZFPM1 FZD1 MET NF1 PDLIM3 DMD NOTCH1 LAMA5 SIRT6 SIX1 LRP2 VPS13B EPHB1 | 1.05e-04 | 436 | 227 | 15 | GO:0007517 |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 1.21e-04 | 2 | 227 | 2 | GO:0050428 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate biosynthetic process | 1.21e-04 | 2 | 227 | 2 | GO:0034036 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | NCOA3 INTU SLC39A1 INHBA MKS1 HIRA FZD1 SLITRK6 KDM6A NOTCH1 RARA RARB AFF3 LAMA5 SIX1 SIX3 ZIC1 BBS7 TP63 LRP2 | 1.28e-04 | 713 | 227 | 20 | GO:0048598 |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 1.29e-04 | 255 | 227 | 11 | GO:0045664 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | BCL9L ILK INHBA FZD1 MAGI2 BMP6 NOTCH1 DNM2 HJV TRIM33 WFIKKN2 LRP2 IL17RD | 1.32e-04 | 347 | 227 | 13 | GO:0090092 |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 1.50e-04 | 176 | 227 | 9 | GO:1900180 | |
| GeneOntologyBiologicalProcess | neuron development | ILK MYO5B UBE4B MYCBP2 CYTH2 TENM2 MKS1 FZD1 MAGI2 MET NF1 HMCN2 ALMS1 FIG4 LRRC7 TRPM1 KIF3C DMD SLITRK6 NOTCH1 CNTN2 MOV10 DNM2 LAMA5 PCARE FRYL CELSR3 RNF6 MTOR LRP2 VPS13B EPHB1 | 1.53e-04 | 1463 | 227 | 32 | GO:0048666 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 1.53e-04 | 73 | 227 | 6 | GO:0001738 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.58e-04 | 218 | 227 | 10 | GO:0090101 | |
| GeneOntologyBiologicalProcess | tube development | NCOA3 INTU ILK AIMP1 PSG6 ESRP1 PGK1 MKS1 FZD1 MET NF1 UBP1 KDM6A NOTCH1 CRISPLD2 FNDC3B RARA RARB KAT6A LAMA5 AMBRA1 SIRT6 SIX1 LDLR NCOR2 BBS7 TP63 PAXIP1 LRP2 MYB EPHB1 | 1.61e-04 | 1402 | 227 | 31 | GO:0035295 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | NCOA3 INHBA PSG6 CYTH2 ZFPM1 PGK1 NF1 ALMS1 ZNF608 DMD NOTCH1 CNTN2 FNDC3B RARA RARB TNFSF18 BICRA SIX3 LDLR THOC5 KIFAP3 NCOR2 RNF6 TP63 BICRAL IL17RD MYB EPHB1 | 1.87e-04 | 1220 | 227 | 28 | GO:0051093 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PSG6 TENM2 MAGI2 HMCN2 CNTN2 ADGRL1 KIFAP3 CELSR3 HMCN1 IGSF9B CDHR4 | 1.93e-04 | 313 | 227 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of secondary heart field cardioblast proliferation | 2.03e-04 | 11 | 227 | 3 | GO:0003266 | |
| GeneOntologyBiologicalProcess | head development | NCOA6 INHBA ZFAND5 MKS1 FZD1 MET NF1 TACC3 NOTCH1 CNTN2 WDR62 CRISPLD2 RARA RARB KAT6A SIX1 SIX3 ZIC1 NCOR2 BBS7 LRP2 VPS13B EPHB1 | 2.15e-04 | 919 | 227 | 23 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 2.40e-04 | 51 | 227 | 5 | GO:1902459 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | NCOA3 ILK ESRP1 MKS1 FZD1 MET KDM6A NOTCH1 RARA LAMA5 SIRT6 SIX1 BBS7 LRP2 | 2.52e-04 | 421 | 227 | 14 | GO:0060562 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | NCOA3 INTU INHBA PSG6 ESRP1 FZD1 MAGI2 MET BMP6 CCDC78 DMD SLITRK6 NOTCH1 FNDC3B IL31RA RARA RARB SIX1 SIX3 NCOR2 TP63 CTNND1 | 2.57e-04 | 870 | 227 | 22 | GO:0030855 |
| GeneOntologyBiologicalProcess | circulatory system development | NCOA6 ILK UBE4B AIMP1 INHBA PSG6 RPS6KA2 ZFAND5 ZFPM1 PGK1 MKS1 FZD1 MET NF1 PDLIM3 UBP1 KDM6A NOTCH1 DNM2 RARA RARB KAT6A SIRT6 SIX1 LDLR NCOR2 MTOR BBS7 PAXIP1 LRP2 EPHB1 | 2.64e-04 | 1442 | 227 | 31 | GO:0072359 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 2.74e-04 | 151 | 227 | 8 | GO:1902106 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 2.99e-04 | 236 | 227 | 10 | GO:0061138 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 3.43e-04 | 55 | 227 | 5 | GO:0060071 | |
| GeneOntologyBiologicalProcess | cardioblast proliferation | 3.47e-04 | 13 | 227 | 3 | GO:0003263 | |
| GeneOntologyBiologicalProcess | regulation of cardioblast proliferation | 3.47e-04 | 13 | 227 | 3 | GO:0003264 | |
| GeneOntologyBiologicalProcess | acetyl-CoA biosynthetic process from pyruvate | 3.47e-04 | 13 | 227 | 3 | GO:0006086 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 3.53e-04 | 85 | 227 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to chromatin | 3.59e-04 | 3 | 227 | 2 | GO:0120187 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 3.59e-04 | 198 | 227 | 9 | GO:0048754 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 3.88e-04 | 159 | 227 | 8 | GO:1903707 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | INTU AIMP1 PSG6 ESRP1 DACH1 BMP6 NF1 ALMS1 PHIP NOTCH1 LAMA5 MUC16 SIRT6 SIX1 ARNT MTOR TP63 | 3.91e-04 | 603 | 227 | 17 | GO:0050673 |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 4.00e-04 | 87 | 227 | 6 | GO:0033143 | |
| GeneOntologyBiologicalProcess | fibroblast proliferation | 4.05e-04 | 160 | 227 | 8 | GO:0048144 | |
| GeneOntologyBiologicalProcess | exocrine system development | 4.06e-04 | 57 | 227 | 5 | GO:0035272 | |
| GeneOntologyBiologicalProcess | neural tube development | 4.16e-04 | 202 | 227 | 9 | GO:0021915 | |
| GeneOntologyBiologicalProcess | developmental growth | NCOA3 ILK MYO5B MYCBP2 MAGI2 PTPN12 ALMS1 DMD SLITRK6 KDM6A NOTCH1 DNM2 RARA RARB SIRT6 SIX1 SIX3 KMT2D RNF6 MTOR GIGYF2 VPS13B | 4.81e-04 | 911 | 227 | 22 | GO:0048589 |
| GeneOntologyBiologicalProcess | muscle tissue development | BCL9L UBE4B ZFAND5 ZFPM1 MET NF1 PDLIM3 DMD NOTCH1 RARA RARB SIRT6 SIX1 MTOR LRP2 EPHB1 | 4.82e-04 | 558 | 227 | 16 | GO:0060537 |
| GeneOntologyBiologicalProcess | response to hypoxia | INHBA PDK1 PDK3 PGK1 NF1 ALAS2 TACC3 KDM6A NOTCH1 ARNT MTOR MYB | 5.03e-04 | 348 | 227 | 12 | GO:0001666 |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 5.09e-04 | 91 | 227 | 6 | GO:0002067 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 5.17e-04 | 166 | 227 | 8 | GO:0098773 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.39e-04 | 92 | 227 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 5.57e-04 | 61 | 227 | 5 | GO:0033866 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 5.57e-04 | 61 | 227 | 5 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 5.57e-04 | 61 | 227 | 5 | GO:0034033 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | INHBA PSG6 ZFPM1 NF1 ZNF608 NOTCH1 RARA TNFSF18 LDLR THOC5 KIFAP3 RNF6 | 5.70e-04 | 353 | 227 | 12 | GO:0010721 |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 5.71e-04 | 93 | 227 | 6 | GO:0060415 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 5.72e-04 | 35 | 227 | 4 | GO:0035116 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 6.03e-04 | 258 | 227 | 10 | GO:0001763 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | INTU AIMP1 PSG6 ESRP1 BMP6 NF1 PHIP NOTCH1 LAMA5 MUC16 SIRT6 SIX1 ARNT MTOR TP63 | 6.03e-04 | 514 | 227 | 15 | GO:0050678 |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 6.05e-04 | 94 | 227 | 6 | GO:0003151 | |
| GeneOntologyBiologicalProcess | heart formation | 6.38e-04 | 36 | 227 | 4 | GO:0060914 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 6.38e-04 | 36 | 227 | 4 | GO:0033146 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | BCL9L ILK FZD1 DMD NOTCH1 DNM2 HJV GRB10 TRIM33 ARNT WFIKKN2 LRP2 IL17RD | 6.81e-04 | 412 | 227 | 13 | GO:0090287 |
| GeneOntologyBiologicalProcess | artery development | 6.86e-04 | 133 | 227 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | sulfate assimilation | 7.13e-04 | 4 | 227 | 2 | GO:0000103 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 7.17e-04 | 134 | 227 | 7 | GO:0045638 | |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 INTU MYCBP2 INHBA FZD1 MET NF1 DMD TACC3 NOTCH1 CNTN2 WDR62 RARA RARB GRIK1 SIX1 SIX3 LDLR ZIC1 NCOR2 MTOR BBS7 LRP2 GIGYF2 VPS13B EPHB1 | 7.34e-04 | 1197 | 227 | 26 | GO:0007417 |
| GeneOntologyBiologicalProcess | response to decreased oxygen levels | INHBA PDK1 PDK3 PGK1 NF1 ALAS2 TACC3 KDM6A NOTCH1 ARNT MTOR MYB | 7.46e-04 | 364 | 227 | 12 | GO:0036293 |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 7.50e-04 | 135 | 227 | 7 | GO:2000177 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast proliferation | 7.50e-04 | 135 | 227 | 7 | GO:0048145 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 7.83e-04 | 136 | 227 | 7 | GO:0030518 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 7.86e-04 | 38 | 227 | 4 | GO:0007435 | |
| GeneOntologyBiologicalProcess | regulation of sulfur metabolic process | 7.98e-04 | 17 | 227 | 3 | GO:0042762 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 8.18e-04 | 178 | 227 | 8 | GO:0022612 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 ILK PSG6 TENM2 MAGI2 BMP6 HMCN2 ZNF608 BTN1A1 LRRC7 NOTCH1 CNTN2 RARA TNFSF18 AMBRA1 PELI1 ADGRL1 KIFAP3 CELSR3 HMCN1 MTOR IGSF9B CTNND1 CDHR4 | 8.32e-04 | 1077 | 227 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | protein K48-linked ubiquitination | 8.38e-04 | 100 | 227 | 6 | GO:0070936 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 8.57e-04 | 67 | 227 | 5 | GO:1902692 | |
| GeneOntologyBiologicalProcess | acetyl-CoA metabolic process | 8.69e-04 | 39 | 227 | 4 | GO:0006084 | |
| GeneOntologyBiologicalProcess | kidney development | DCHS2 ILK MAGI2 BMP6 NF1 NOTCH1 RARA RARB LAMA5 SIX1 LRP2 CTNND1 | 9.01e-04 | 372 | 227 | 12 | GO:0001822 |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 9.30e-04 | 102 | 227 | 6 | GO:0048644 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 1.01e-03 | 142 | 227 | 7 | GO:0006090 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 1.03e-03 | 104 | 227 | 6 | GO:0007405 | |
| GeneOntologyBiologicalProcess | intracellular transport | DDX19B INTU MYO1D MYO5B PEX12 DTX3L SPTBN5 STRADB RBSN AP2M1 NF1 ALMS1 UBR5 LRRC7 TACC3 PHIP NOTCH1 CABP1 EXOC6 MYO19 SIRT6 SIX3 LDLR THOC5 ZIC1 CAPN10 KIFAP3 BBS7 LRP2 VPS13B | 1.04e-03 | 1496 | 227 | 30 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of cell development | ILK MYO5B INHBA PSG6 ZFPM1 MET NF1 ZNF608 NOTCH1 WDR62 RARA SH3RF1 TNFSF18 KAT6A AMBRA1 LDLR THOC5 KIFAP3 ARNT RNF6 MTOR LRP2 SPEN MYB | 1.04e-03 | 1095 | 227 | 24 | GO:0060284 |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA3 NCOA6 INTU SLC39A1 ZFAND5 MKS1 FZD1 NF1 KDM6A NOTCH1 RARA AMBRA1 SIX1 THOC5 NCOR2 FOXD3 ARNT KMT2D LRP2 CNOT1 MYB | 1.09e-03 | 906 | 227 | 21 | GO:0043009 |
| GeneOntologyBiologicalProcess | negative regulation of protein import into nucleus | 1.12e-03 | 19 | 227 | 3 | GO:0042308 | |
| GeneOntologyCellularComponent | dendrite | LYPD6 ILK MYO1D MYO5B RGS11 TENM2 ADCY2 MAGI2 MET NF1 MCRS1 C4B LRRC7 TRPM1 KIF3C CABP1 RARA PCLO GRIK1 PABPC1 MTOR TP63 LRP2 GIGYF2 IGSF9B CTNND1 EPHB1 | 9.57e-07 | 858 | 230 | 27 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | LYPD6 ILK MYO1D MYO5B RGS11 TENM2 ADCY2 MAGI2 MET NF1 MCRS1 C4B LRRC7 TRPM1 KIF3C CABP1 RARA PCLO GRIK1 PABPC1 MTOR TP63 LRP2 GIGYF2 IGSF9B CTNND1 EPHB1 | 1.00e-06 | 860 | 230 | 27 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | LYPD6 ILK MYO1D MYO5B RGS11 TENM2 ADCY2 MAGI2 MET NF1 HMCN2 SCN1A MCRS1 C4B LRRC7 TRPM1 KIF3C DMD CNTN2 CABP1 RARA PCLO GRIK1 PABPC1 LDLR MTOR TP63 LRP2 PAM GIGYF2 IGSF9B CTNND1 EPHB1 | 1.85e-06 | 1228 | 230 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | axon | ILK MYO1D MYCBP2 CYTH2 TENM2 NF1 HMCN2 SCN1A C4B LRRC7 TRPM1 KIF3C DMD CNTN2 DNM2 CABP1 EXOC6 MICAL1 IL31RA PCLO ADGRL1 GRIK1 RNF6 LRP2 CTNND1 EPHB1 | 6.05e-06 | 891 | 230 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | MLL3/4 complex | 6.59e-06 | 12 | 230 | 4 | GO:0044666 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.87e-05 | 75 | 230 | 7 | GO:0035097 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MYO5B INPP4A CYTH2 TENM2 MAGI2 AP2M1 NF1 LRRC7 TACC3 NOTCH1 DNM2 CABP1 PCLO LAMA5 ADGRL1 GRIK1 KIFAP3 CELSR3 MTOR CPNE4 CTNND1 EPHB1 | 1.06e-04 | 817 | 230 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | site of polarized growth | CYTH2 TENM2 TRPM1 KIF3C DNM2 EXOC6 PCLO ADGRL1 FRYL LRP2 CTNND1 | 1.20e-04 | 253 | 230 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | P-TEFb complex | 1.21e-04 | 2 | 230 | 2 | GO:0070691 | |
| GeneOntologyCellularComponent | nuclear body | CDK9 ESRP1 DACH1 TENM2 DDX1 HIRA SCN1A AIPL1 HCFC2 TCF20 KAT6A AFF3 SMC4 MAU2 NCOR2 ARNT GTF2H4 RNF6 MTOR TKT POLI EHMT1 MAML2 | 1.67e-04 | 903 | 230 | 23 | GO:0016604 |
| GeneOntologyCellularComponent | methyltransferase complex | 1.94e-04 | 108 | 230 | 7 | GO:0034708 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | CDK9 DDX19B PABPC4 DDX1 HELZ KIF3C MOV10 PABPC1 POLI GIGYF2 CNOT1 | 2.05e-04 | 269 | 230 | 11 | GO:0036464 |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L NCOA3 NCOA6 DACH1 ZFPM1 GTF3C4 MED24 MGA RARA SIX1 SIX3 NCOR2 FOXD3 ARNT GTF2H4 SPEN MYB | 3.42e-04 | 596 | 230 | 17 | GO:0005667 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | CDK9 DDX19B PABPC4 DDX1 HELZ KIF3C MOV10 PABPC1 POLI GIGYF2 CNOT1 | 3.56e-04 | 287 | 230 | 11 | GO:0035770 |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 5.72e-04 | 35 | 230 | 4 | GO:0099243 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 6.76e-04 | 96 | 230 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | synaptic membrane | CYTH2 TENM2 MAGI2 MET AP2M1 SCN1A LRRC7 DMD NOTCH1 CNTN2 DNM2 IL31RA ADGRL1 GRIK1 CELSR3 IGSF9B | 7.71e-04 | 583 | 230 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic specialization | INPP4A CYTH2 MAGI2 LRRC7 DMD TACC3 NOTCH1 DNM2 CABP1 PCLO GRIK1 CELSR3 IGSF9B CTNND1 | 1.43e-03 | 503 | 230 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | cell cortex region | 1.49e-03 | 45 | 230 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | postsynaptic density | INPP4A MAGI2 LRRC7 DMD TACC3 NOTCH1 DNM2 CABP1 PCLO GRIK1 CELSR3 IGSF9B CTNND1 | 1.54e-03 | 451 | 230 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | growth cone | 1.63e-03 | 245 | 230 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.70e-03 | 78 | 230 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 1.73e-03 | 22 | 230 | 3 | GO:0098890 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CYTH2 TENM2 MAGI2 MET LRRC7 DMD NOTCH1 CNTN2 DNM2 GRIK1 CELSR3 IGSF9B | 1.85e-03 | 405 | 230 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | postsynapse | MYO5B INPP4A CYTH2 ZZEF1 TENM2 MAGI2 MET AP2M1 LRRC7 DMD TACC3 NOTCH1 CNTN2 DNM2 CABP1 PCLO GRIK1 KIFAP3 CELSR3 MTOR IGSF9B CTNND1 | 2.01e-03 | 1018 | 230 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 2.24e-03 | 24 | 230 | 3 | GO:0032806 | |
| GeneOntologyCellularComponent | neuronal cell body | LYPD6 ILK MYO1D MYO5B MET HMCN2 SCN1A MCRS1 C4B KIF3C DMD CNTN2 CABP1 PCLO GRIK1 MTOR PAM GIGYF2 IGSF9B | 2.30e-03 | 835 | 230 | 19 | GO:0043025 |
| GeneOntologyCellularComponent | asymmetric synapse | INPP4A MAGI2 LRRC7 DMD TACC3 NOTCH1 DNM2 CABP1 PCLO GRIK1 CELSR3 IGSF9B CTNND1 | 2.52e-03 | 477 | 230 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | PML body | 2.63e-03 | 125 | 230 | 6 | GO:0016605 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 ILK PSG6 CYTH2 TBC1D2 TENM2 FZD1 DOCK5 MAGI2 PTPN12 PDLIM3 SCN1A LRRC7 DMD NOTCH1 DNM2 KIF23 AMBRA1 PABPC1 HMCN1 CTNND1 | 2.67e-03 | 976 | 230 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | centriole | 3.01e-03 | 172 | 230 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | pyruvate dehydrogenase complex | 3.23e-03 | 8 | 230 | 2 | GO:0045254 | |
| GeneOntologyCellularComponent | distal axon | ILK CYTH2 TENM2 KIF3C DNM2 EXOC6 MICAL1 PCLO ADGRL1 GRIK1 LRP2 CTNND1 | 3.31e-03 | 435 | 230 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | cell body | LYPD6 ILK MYO1D MYO5B MET HMCN2 SCN1A MCRS1 C4B KIF3C DMD CNTN2 CABP1 PCLO CCT2 GRIK1 MTOR PAM GIGYF2 IGSF9B | 3.34e-03 | 929 | 230 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 3.35e-03 | 56 | 230 | 4 | GO:0008023 | |
| HumanPheno | Nasolacrimal duct obstruction | 1.23e-05 | 36 | 76 | 6 | HP:0000579 | |
| HumanPheno | Absent nipple | 1.40e-05 | 11 | 76 | 4 | HP:0002561 | |
| HumanPheno | Lip pit | 2.96e-05 | 13 | 76 | 4 | HP:0100267 | |
| HumanPheno | Abnormal earlobe morphology | 3.00e-05 | 137 | 76 | 10 | HP:0000363 | |
| HumanPheno | Branchial sinus | 3.12e-05 | 5 | 76 | 3 | HP:0100272 | |
| HumanPheno | Tetralogy of Fallot | INTU UBE4B HIRA FIG4 KDM6A NOTCH1 BICRA SIX3 KMT2D EHMT1 SPEN | 7.84e-05 | 185 | 76 | 11 | HP:0001636 |
| HumanPheno | Precocious puberty | NF1 ALMS1 SCN1A KDM6A GRB10 SIX3 PAPSS2 KMT2D TP63 EHMT1 SPEN | 8.23e-05 | 186 | 76 | 11 | HP:0000826 |
| HumanPheno | Abnormal lacrimal duct morphology | 8.53e-05 | 50 | 76 | 6 | HP:0011481 | |
| HumanPheno | Focal impaired awareness seizure | 9.16e-05 | 126 | 76 | 9 | HP:0002384 | |
| HumanPheno | Early onset of sexual maturation | NF1 ALMS1 SCN1A KDM6A GRB10 SIX3 PAPSS2 KMT2D TP63 EHMT1 SPEN | 9.52e-05 | 189 | 76 | 11 | HP:0100000 |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 1.07e-04 | 52 | 76 | 6 | HP:0007334 | |
| HumanPheno | Abnormal midface morphology | UBE4B PEX12 MKS1 HIRA AP2M1 NF1 KDM6A TCF20 BICRA PCLO KAT6A SIX1 SIX3 ZIC1 KMT2D MTOR BBS7 TP63 EHMT1 LRP2 SPEN CNOT1 VPS13B | 1.47e-04 | 704 | 76 | 23 | HP:0000309 |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | NCOA6 INTU UBE4B MKS1 MET SLC13A4 NF1 TACC3 BICRA KAT6A LAMA5 AMBRA1 NCOR2 PAM SPEN MYB | 3.92e-07 | 263 | 184 | 16 | MP:0011099 |
| MousePheno | abnormal placenta vasculature | NCOA6 ERG MYCBP2 ESRP1 MED24 UBP1 NOTCH1 LAMA5 FRYL SIX1 NCOR2 ARNT PAXIP1 | 1.53e-06 | 192 | 184 | 13 | MP:0003231 |
| MousePheno | abnormal extraembryonic tissue morphology | BCL9L NCOA6 ILK ERG MYCBP2 ESRP1 ZFPM1 HIRA MED24 MET PTPN12 UBR5 UBP1 MCRS1 MGA KDM6A NOTCH1 LAMA5 GRB10 FRYL SIX1 TRIM33 NCOR2 FOXD3 ARNT MTOR TP63 PAXIP1 LRP2 PAM | 2.62e-06 | 908 | 184 | 30 | MP:0002086 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | NCOA6 INTU ILK MYO5B UBE4B MYCBP2 INHBA INPP4A ESRP1 DACH1 ZFAND5 MKS1 MAGI2 MET SLC13A4 NF1 ZNRF3 SCN1A TACC3 KDM6A DNM2 FNDC3B BICRA KAT6A LAMA5 AMBRA1 POU2F2 SIX1 SIX3 ZIC1 NCOR2 CELSR3 TP63 LRP2 PAM SPEN MYB | 2.96e-06 | 1269 | 184 | 37 | MP:0011111 |
| MousePheno | lethality throughout fetal growth and development | NCOA6 INTU UBE4B ZFPM1 MKS1 MET SLC13A4 NF1 SCN1A TACC3 BICRA KAT6A LAMA5 AMBRA1 FRYL NCOR2 PAM SPEN MYB | 4.71e-06 | 435 | 184 | 19 | MP:0006208 |
| MousePheno | abnormal prenatal body size | BCL9L NCOA3 NCOA6 ILK ERG AIMP1 ZFPM1 HIRA MED24 MET PTPN12 AARS2 UBR5 UBP1 TACC3 KDM6A PHIP NOTCH1 CRISPLD2 CUL1 RBM45 BICRA KAT6A AFF3 LAMA5 GRB10 TRIM33 ARNT MTOR TP63 PAXIP1 EHMT1 LRP2 | 8.41e-06 | 1116 | 184 | 33 | MP:0010866 |
| MousePheno | abnormal prenatal growth/weight/body size | BCL9L NCOA3 NCOA6 ILK ERG SLC39A1 AIMP1 ESRP1 ZFPM1 HIRA MED24 MET PTPN12 AARS2 UBR5 UBP1 TACC3 KDM6A PHIP NOTCH1 WDR62 CRISPLD2 CUL1 TCF20 RBM45 BICRA KAT6A AFF3 LAMA5 GRB10 SIX1 TRIM33 NCOR2 ARNT MTOR TP63 PAXIP1 EHMT1 LRP2 BICRAL | 8.60e-06 | 1493 | 184 | 40 | MP:0004196 |
| MousePheno | abnormal craniofacial morphology | NCOA3 NCOA6 SLC39A1 INHBA ESRP1 ZFAND5 ZZEF1 MKS1 HIRA MET SLC13A4 NF1 BBX UBR5 FIG4 TACC3 KDM6A PHIP NOTCH1 DNM2 RARA RARB RBM45 KAT6A AFF3 LAMA5 AMBRA1 SIRT6 SIX1 SIX3 PAPSS2 NCOR2 ARNT KMT2D TP63 EHMT1 LRP2 | 1.75e-05 | 1372 | 184 | 37 | MP:0000428 |
| MousePheno | craniofacial phenotype | NCOA3 NCOA6 SLC39A1 INHBA ESRP1 ZFAND5 ZZEF1 MKS1 HIRA MET SLC13A4 NF1 BBX UBR5 FIG4 TACC3 KDM6A PHIP NOTCH1 DNM2 RARA RARB RBM45 KAT6A AFF3 LAMA5 AMBRA1 SIRT6 SIX1 SIX3 PAPSS2 NCOR2 ARNT KMT2D TP63 EHMT1 LRP2 | 1.75e-05 | 1372 | 184 | 37 | MP:0005382 |
| MousePheno | abnormal placenta morphology | BCL9L NCOA6 ERG MYCBP2 ESRP1 MED24 MET UBP1 MGA KDM6A NOTCH1 LAMA5 GRB10 FRYL SIX1 NCOR2 FOXD3 ARNT MTOR PAXIP1 | 1.97e-05 | 525 | 184 | 20 | MP:0001711 |
| MousePheno | abnormal embryo size | BCL9L NCOA3 NCOA6 ILK ERG AIMP1 ZFPM1 HIRA MED24 MET PTPN12 AARS2 UBR5 UBP1 TACC3 KDM6A PHIP NOTCH1 CRISPLD2 CUL1 RBM45 BICRA LAMA5 TRIM33 ARNT MTOR PAXIP1 EHMT1 LRP2 | 2.01e-05 | 956 | 184 | 29 | MP:0001697 |
| MousePheno | abnormal muscle weight | 2.23e-05 | 44 | 184 | 6 | MP:0004233 | |
| MousePheno | abnormal embryonic growth/weight/body size | BCL9L NCOA3 NCOA6 ILK ERG SLC39A1 AIMP1 ESRP1 ZFPM1 HIRA MED24 MET PTPN12 AARS2 UBR5 UBP1 TACC3 KDM6A PHIP NOTCH1 CRISPLD2 CUL1 RBM45 BICRA LAMA5 GRB10 SIX1 TRIM33 NCOR2 ARNT MTOR PAXIP1 EHMT1 LRP2 BICRAL | 2.96e-05 | 1295 | 184 | 35 | MP:0002088 |
| MousePheno | abnormal skeletal muscle weight | 3.44e-05 | 29 | 184 | 5 | MP:0010237 | |
| MousePheno | abnormal embryonic erythropoiesis | 4.08e-05 | 30 | 184 | 5 | MP:0004229 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | BCL9L NCOA6 ILK ERG ZFPM1 HIRA MED24 MET PTPN12 NF1 UBR5 UBP1 ALAS2 TACC3 KDM6A NOTCH1 MAU2 ARNT KMT2D MTOR PAXIP1 EHMT1 BICRAL | 4.76e-05 | 700 | 184 | 23 | MP:0011098 |
| MousePheno | abnormal cardiovascular development | NCOA6 INTU ILK ERG ZFPM1 MKS1 HIRA MED24 PTPN12 SLC13A4 NF1 UBR5 UBP1 KDM6A NOTCH1 KAT6A LAMA5 SIX1 NCOR2 ARNT PAXIP1 LRP2 PAM SPEN MYB | 5.16e-05 | 802 | 184 | 25 | MP:0002925 |
| MousePheno | abnormal placenta labyrinth morphology | 5.20e-05 | 194 | 184 | 11 | MP:0001716 | |
| MousePheno | decreased embryo size | BCL9L NCOA3 NCOA6 ERG ZFPM1 HIRA MED24 MET AARS2 UBR5 UBP1 TACC3 KDM6A NOTCH1 CUL1 BICRA TRIM33 ARNT MTOR PAXIP1 EHMT1 LRP2 | 5.56e-05 | 659 | 184 | 22 | MP:0001698 |
| MousePheno | abnormal cranium morphology | NCOA3 INHBA ESRP1 ZFAND5 ZZEF1 MKS1 BBX FIG4 TACC3 KDM6A PHIP RARA RARB KAT6A AFF3 LAMA5 AMBRA1 SIRT6 SIX1 SIX3 PAPSS2 KMT2D TP63 EHMT1 LRP2 | 6.43e-05 | 813 | 184 | 25 | MP:0000438 |
| MousePheno | embryonic lethality during organogenesis | BCL9L NCOA6 INTU ILK ERG ZFPM1 MKS1 HIRA MED24 MET PTPN12 NF1 UBR5 UBP1 ALAS2 TACC3 KDM6A NOTCH1 AMBRA1 MAU2 ARNT KMT2D MTOR PAXIP1 EHMT1 BICRAL | 8.14e-05 | 876 | 184 | 26 | MP:0006207 |
| MousePheno | edema | INTU ERG UBE4B ESRP1 ZFAND5 ZFPM1 MKS1 HIRA PTPN12 SLC13A4 NF1 PDLIM3 KDM6A RBM45 BICRA KAT6A SIX1 NCOR2 PAM MYB | 8.16e-05 | 581 | 184 | 20 | MP:0001785 |
| MousePheno | abnormal fluid regulation | NCOA6 INTU ERG UBE4B ESRP1 ZFAND5 ZFPM1 MKS1 HIRA PTPN12 SLC13A4 NF1 PDLIM3 UBR5 LRRC7 KDM6A RBM45 BICRA KAT6A POU2F2 SIX1 NCOR2 TP63 PAM MYB | 8.29e-05 | 826 | 184 | 25 | MP:0001784 |
| MousePheno | abnormal craniofacial bone morphology | NCOA3 INHBA ESRP1 ZFAND5 ZZEF1 MKS1 BBX FIG4 TACC3 KDM6A PHIP RARA RARB KAT6A AFF3 LAMA5 AMBRA1 SIRT6 SIX1 SIX3 PAPSS2 KMT2D TP63 EHMT1 LRP2 | 8.45e-05 | 827 | 184 | 25 | MP:0002116 |
| MousePheno | abnormal embryonic erythrocyte morphology | 1.01e-04 | 36 | 184 | 5 | MP:0004230 | |
| MousePheno | abnormal embryonic hematopoiesis | 1.10e-04 | 58 | 184 | 6 | MP:0003396 | |
| MousePheno | myocardial trabeculae hypoplasia | 1.10e-04 | 58 | 184 | 6 | MP:0010503 | |
| MousePheno | abnormal axial skeleton morphology | NCOA3 INTU INHBA PABPC4 ESRP1 ZFAND5 ZZEF1 EMSY MKS1 HIRA BMP6 FBXO25 SLC13A4 BBX FIG4 DMD TACC3 KDM6A PHIP NOTCH1 RARA RARB KAT6A AFF3 LAMA5 AMBRA1 MAU2 SIRT6 SIX1 SIX3 PAPSS2 ZIC1 KMT2D TP63 EHMT1 LRP2 | 1.46e-04 | 1458 | 184 | 36 | MP:0002114 |
| MousePheno | perinatal lethality, complete penetrance | ILK MYO5B MYCBP2 INHBA ESRP1 DACH1 ZFAND5 MKS1 MAGI2 MET ZNRF3 TACC3 KDM6A DNM2 FNDC3B KAT6A POU2F2 SIX1 SIX3 CELSR3 TP63 LRP2 | 1.71e-04 | 712 | 184 | 22 | MP:0011089 |
| MousePheno | absent diaphragm | 1.72e-04 | 2 | 184 | 2 | MP:0011883 | |
| MousePheno | abnormal extraembryonic tissue physiology | NCOA6 ERG ZFPM1 HIRA MED24 MET SLC13A4 UBR5 ALAS2 FRYL FOXD3 ARNT PAXIP1 MYB | 1.91e-04 | 345 | 184 | 14 | MP:0004264 |
| MousePheno | abnormal mouth morphology | NCOA3 NCOA6 INHBA ESRP1 ZZEF1 MKS1 MET SLC13A4 NF1 BBX FIG4 DNM2 KAT6A AFF3 LAMA5 SIRT6 SIX1 PAPSS2 TP63 EHMT1 LRP2 | 1.99e-04 | 670 | 184 | 21 | MP:0000452 |
| MousePheno | abnormal innervation | MYCBP2 TENM2 MET SLITRK6 CNTN2 IGSF3 MICAL1 KAT6A CELSR3 EPHB1 | 2.39e-04 | 193 | 184 | 10 | MP:0002184 |
| MousePheno | decreased skeletal muscle weight | 2.51e-04 | 24 | 184 | 4 | MP:0010239 | |
| MousePheno | abnormal embryonic tissue morphology | INTU ILK INHBA MKS1 HIRA MED24 PTPN12 NF1 ZNRF3 UBR5 MCRS1 TACC3 MGA KDM6A NOTCH1 KAT6A LAMA5 AMBRA1 SIX1 SIX3 TRIM33 FOXD3 ARNT MTOR TP63 PAXIP1 EHMT1 LRP2 MYB | 3.09e-04 | 1116 | 184 | 29 | MP:0002085 |
| MousePheno | abnormal viscerocranium morphology | NCOA3 INHBA ESRP1 ZFAND5 ZZEF1 MKS1 BBX FIG4 RARA KAT6A AFF3 LAMA5 SIRT6 SIX1 PAPSS2 KMT2D TP63 EHMT1 LRP2 | 3.09e-04 | 593 | 184 | 19 | MP:0005274 |
| MousePheno | pallor | NCOA6 ILK ZFPM1 SLC13A4 NF1 UBP1 ALAS2 EXOC6 KAT6A PAXIP1 MYB | 3.27e-04 | 239 | 184 | 11 | MP:0003717 |
| MousePheno | trabecula carnea hypoplasia | 3.31e-04 | 46 | 184 | 5 | MP:0000295 | |
| MousePheno | increased muscle weight | 3.42e-04 | 11 | 184 | 3 | MP:0003397 | |
| MousePheno | abnormal forebrain morphology | NCOA6 INTU MYCBP2 INPP4A TENM2 MKS1 HIRA SCN1A DMD KDM6A WDR62 MICAL1 TCF20 AFF3 AMBRA1 SIX1 SIX3 LDLR NCOR2 ARNT KMT2D CELSR3 MTOR BBS7 EHMT1 LRP2 CTNND1 EPHB1 | 3.65e-04 | 1072 | 184 | 28 | MP:0000783 |
| MousePheno | abnormal facial morphology | NCOA3 NCOA6 INHBA ESRP1 ZZEF1 MKS1 MET SLC13A4 NF1 BBX FIG4 TACC3 DNM2 RBM45 KAT6A AFF3 LAMA5 AMBRA1 SIRT6 SIX1 PAPSS2 KMT2D TP63 EHMT1 LRP2 | 3.70e-04 | 910 | 184 | 25 | MP:0003743 |
| MousePheno | perinatal lethality | NCOA6 ILK MYO5B MYCBP2 INHBA ESRP1 DACH1 ZFAND5 ZFPM1 MKS1 MAGI2 MET ZNRF3 SCN1A TACC3 KDM6A DNM2 FNDC3B RARA KAT6A GRB10 POU2F2 SIX1 SIX3 ZIC1 CELSR3 TP63 LRP2 GIGYF2 | 3.79e-04 | 1130 | 184 | 29 | MP:0002081 |
| MousePheno | heart hypoplasia | 4.18e-04 | 103 | 184 | 7 | MP:0002740 | |
| MousePheno | abnormal telencephalon morphology | NCOA6 INTU MYCBP2 INPP4A TENM2 MKS1 SCN1A WDR62 MICAL1 TCF20 AFF3 AMBRA1 SIX3 LDLR NCOR2 KMT2D CELSR3 MTOR BBS7 EHMT1 LRP2 CTNND1 EPHB1 | 4.22e-04 | 812 | 184 | 23 | MP:0000787 |
| MousePheno | abnormal hepatobiliary system development | 4.23e-04 | 74 | 184 | 6 | MP:0003943 | |
| MousePheno | embryonic growth retardation | NCOA6 ILK ERG SLC39A1 ESRP1 HIRA PTPN12 UBR5 UBP1 TACC3 KDM6A NOTCH1 BICRA GRB10 SIX1 TRIM33 NCOR2 ARNT MTOR PAXIP1 EHMT1 BICRAL | 4.46e-04 | 763 | 184 | 22 | MP:0003984 |
| MousePheno | prenatal growth retardation | NCOA6 ILK ERG SLC39A1 ESRP1 HIRA PTPN12 UBR5 UBP1 TACC3 KDM6A NOTCH1 WDR62 TCF20 BICRA GRB10 SIX1 TRIM33 NCOR2 ARNT MTOR PAXIP1 EHMT1 BICRAL | 4.53e-04 | 869 | 184 | 24 | MP:0010865 |
| MousePheno | abnormal skin appearance | NCOA6 LYPD6 ILK MYO5B ZFPM1 SLC13A4 NF1 UBP1 ALAS2 EXOC6 KAT6A LDLR TP63 PAXIP1 SPEN MYB | 5.22e-04 | 473 | 184 | 16 | MP:0009931 |
| MousePheno | pale yolk sac | 6.21e-04 | 110 | 184 | 7 | MP:0001722 | |
| MousePheno | abnormal myocardial trabeculae morphology | 6.35e-04 | 144 | 184 | 8 | MP:0002189 | |
| MousePheno | abnormal jaw morphology | NCOA3 INHBA ESRP1 ZZEF1 MKS1 BBX FIG4 KAT6A AFF3 LAMA5 SIRT6 SIX1 PAPSS2 KMT2D TP63 EHMT1 LRP2 | 6.38e-04 | 530 | 184 | 17 | MP:0000454 |
| MousePheno | abnormal head morphology | NCOA3 NCOA6 INHBA ESRP1 ZZEF1 MKS1 HIRA MET SLC13A4 NF1 BBX FIG4 TACC3 WDR62 DNM2 RBM45 KAT6A AFF3 LAMA5 AMBRA1 SIRT6 SIX1 PAPSS2 ARNT KMT2D TP63 EHMT1 LRP2 | 7.30e-04 | 1120 | 184 | 28 | MP:0000432 |
| MousePheno | pericardial edema | 7.33e-04 | 82 | 184 | 6 | MP:0001787 | |
| MousePheno | abnormal brain development | NCOA6 INTU INPP4A MKS1 HIRA MET UBR5 KDM6A PHIP WDR62 DNM2 TCF20 LAMA5 AMBRA1 SIX3 ZIC1 CELSR3 MTOR LRP2 | 7.57e-04 | 638 | 184 | 19 | MP:0000913 |
| MousePheno | abnormal blood vessel morphology | NCOA6 ILK ERG UBE4B MYCBP2 ESRP1 ZFAND5 ZFPM1 MKS1 HIRA MED24 MAGI2 MET PTPN12 SLC13A4 NF1 UBR5 UBP1 PHLPP1 NOTCH1 MOV10 DNM2 RARB KAT6A LAMA5 FRYL SIX1 LDLR NCOR2 ARNT PAXIP1 LRP2 PAM MYB | 7.79e-04 | 1472 | 184 | 34 | MP:0001614 |
| MousePheno | abnormal skeletal muscle mass | 7.95e-04 | 149 | 184 | 8 | MP:0004817 | |
| MousePheno | abnormal pericardium morphology | 7.99e-04 | 225 | 184 | 10 | MP:0000288 | |
| MousePheno | abnormal neural tube morphology | INTU MKS1 HIRA MED24 PTPN12 NF1 ZNRF3 KDM6A NOTCH1 LAMA5 AMBRA1 SIX1 SIX3 ARNT MTOR EHMT1 LRP2 MYB | 8.08e-04 | 591 | 184 | 18 | MP:0002151 |
| MousePheno | muscle hypoplasia | 9.08e-04 | 15 | 184 | 3 | MP:0000734 | |
| Domain | BCDHK_Adom3 | 1.67e-05 | 5 | 224 | 3 | PF10436 | |
| Domain | PolyA | 1.67e-05 | 5 | 224 | 3 | SM00517 | |
| Domain | - | 1.67e-05 | 5 | 224 | 3 | 1.10.1900.10 | |
| Domain | PABP | 1.67e-05 | 5 | 224 | 3 | PF00658 | |
| Domain | His_kinase_dom | 1.67e-05 | 5 | 224 | 3 | IPR005467 | |
| Domain | HIS_KIN | 1.67e-05 | 5 | 224 | 3 | PS50109 | |
| Domain | BCDHK/PDK_N | 1.67e-05 | 5 | 224 | 3 | IPR018955 | |
| Domain | PABC | 1.67e-05 | 5 | 224 | 3 | PS51309 | |
| Domain | PABP_HYD | 1.67e-05 | 5 | 224 | 3 | IPR002004 | |
| Domain | - | 1.67e-05 | 5 | 224 | 3 | 1.20.140.20 | |
| Domain | - | 9.80e-05 | 39 | 224 | 5 | 2.120.10.30 | |
| Domain | EGF_CA | 1.13e-04 | 122 | 224 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.26e-04 | 124 | 224 | 8 | IPR001881 | |
| Domain | Sulfurylase_cat_dom | 1.43e-04 | 2 | 224 | 2 | IPR024951 | |
| Domain | ATP-sulfurylase | 1.43e-04 | 2 | 224 | 2 | PF01747 | |
| Domain | PUA_2 | 1.43e-04 | 2 | 224 | 2 | PF14306 | |
| Domain | GSCR1_dom | 1.43e-04 | 2 | 224 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 1.43e-04 | 2 | 224 | 2 | PF15249 | |
| Domain | APS_kinase | 1.43e-04 | 2 | 224 | 2 | IPR002891 | |
| Domain | Sulphate_adenylyltransferase | 1.43e-04 | 2 | 224 | 2 | IPR002650 | |
| Domain | ATP-Sase_PUA-like_dom | 1.43e-04 | 2 | 224 | 2 | IPR025980 | |
| Domain | ASX_HYDROXYL | 2.02e-04 | 100 | 224 | 7 | PS00010 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.18e-04 | 46 | 224 | 5 | IPR011042 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.90e-04 | 106 | 224 | 7 | IPR000152 | |
| Domain | Phosphoglycerate_kinase | 4.26e-04 | 3 | 224 | 2 | IPR001576 | |
| Domain | G2F | 8.46e-04 | 4 | 224 | 2 | PF07474 | |
| Domain | SSU_processome_Utp12 | 8.46e-04 | 4 | 224 | 2 | IPR007148 | |
| Domain | Retinoic_acid_rcpt | 8.46e-04 | 4 | 224 | 2 | IPR003078 | |
| Domain | NIDOGEN_G2 | 8.46e-04 | 4 | 224 | 2 | PS50993 | |
| Domain | GFP | 8.46e-04 | 4 | 224 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 8.46e-04 | 4 | 224 | 2 | IPR006605 | |
| Domain | Utp12 | 8.46e-04 | 4 | 224 | 2 | PF04003 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 9.97e-06 | 42 | 169 | 6 | M48018 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.22e-05 | 65 | 169 | 7 | M39682 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.20e-05 | 48 | 169 | 6 | M288 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA3 NCOA6 AIMP1 RPS6KA2 PSMD13 HIRA SPTBN5 MED24 MET AP2M1 SCN1A TRPM1 TUBA4B KDM6A NOTCH1 CNTN2 MOV10 DNM2 HJV RARA RARB GRB10 SIX1 PABPC1 ZIC1 TRIM33 NCOR2 FOXD3 KMT2D TP63 PAXIP1 MAML2 CNOT1 MYB EPHB1 | 3.15e-05 | 1432 | 169 | 35 | M509 |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 3.30e-05 | 6 | 169 | 3 | MM1447 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 8.50e-05 | 38 | 169 | 5 | MM17073 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 8.74e-05 | 61 | 169 | 6 | M39540 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.55e-04 | 43 | 169 | 5 | M27443 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | CDK9 PSMD13 ZFPM1 GTF3C4 MLLT1 MCRS1 HCFC2 MGA KDM6A NOTCH1 CUL1 RARA RARB KAT6A POU2F2 CCNT1 NCOR2 ARNT KMT2D GTF2H4 MTOR TP63 PAXIP1 EHMT1 MAML2 CNOT1 | 2.06e-04 | 1022 | 169 | 26 | MM15436 |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.09e-04 | 170 | 169 | 9 | M941 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 2.43e-04 | 26 | 169 | 4 | M47439 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 2.91e-04 | 49 | 169 | 5 | MM15186 | |
| Pathway | WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS | 3.44e-04 | 12 | 169 | 3 | MM15927 | |
| Pubmed | BCL9L NCOA3 NOL4 NCOA6 ERG MYO1D AIMP1 PABPC4 DACH1 PSMD13 EMSY DDX1 HIRA MED24 AP2M1 BBX ALMS1 ZNF608 MLLT1 HELZ MCRS1 HCFC2 MGA KDM6A MOV10 KIF23 TCF20 BICRA CCT2 PABPC1 TRIM33 NCOR2 ARNT KMT2D PAXIP1 EHMT1 LRP2 GIGYF2 USP54 SPEN CNOT1 MYB | 5.30e-16 | 1429 | 232 | 42 | 35140242 | |
| Pubmed | CDK9 DDX19B NCOA3 NCOA6 ILK MYCBP2 PABPC4 DACH1 PGK1 EMSY DDX1 MED24 AP2M1 UBR5 KDM6A DNM2 CUL1 RARA TCF20 BICRA SMC4 CCT2 PABPC1 TRIM33 CCNT1 NCOR2 ARNT KMT2D TKT PAXIP1 EHMT1 BICRAL SPEN CNOT1 MYB | 2.10e-14 | 1103 | 232 | 35 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDK9 NCOA6 UBE4B MYCBP2 RPS6KA2 ZFPM1 ZZEF1 HIRA FZD1 ZNRF3 MLLT1 NOTCH1 IGSF3 SH3RF1 BICRA NLRX1 KAT6A LAMA5 GRB10 AMBRA1 ADGRL1 FRYL LDLR NCOR2 KMT2D CELSR3 MTOR TMEM268 PAXIP1 EHMT1 IL17RD SPEN CYTH4 | 6.64e-13 | 1105 | 232 | 33 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA3 NOL4 NCOA6 EMSY HIRA ALMS1 ZNF608 MGA KDM6A TCF20 BICRA TRIM33 NCOR2 ARNT KMT2D PAXIP1 EHMT1 SPEN | 3.54e-12 | 351 | 232 | 19 | 38297188 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | CDK9 NCOA3 NOL4 WDR3 AARS2 ZNF608 UBP1 MGA KDM6A TCF20 BICRA PCLO CCT2 TRIM33 NCOR2 KMT2D PAXIP1 BICRAL USP54 | 3.11e-11 | 398 | 232 | 19 | 35016035 |
| Pubmed | BCL9L NCOA3 NCOA6 GTF3C4 EMSY HIRA MED24 ZNF608 MCRS1 MGA KDM6A TCF20 TRIM33 CCNT1 KMT2D PAXIP1 | 4.44e-11 | 268 | 232 | 16 | 33640491 | |
| Pubmed | DDX19B NCOA3 NCOA6 MYO1D AIMP1 ADCY2 NF1 UBP1 MCRS1 KDM6A IGSF3 DNM2 EXOC6 TCF20 MUC16 NCOR2 KMT2D BBS7 PAXIP1 EHMT1 IL17RD SPEN CNOT1 | 6.95e-11 | 638 | 232 | 23 | 31182584 | |
| Pubmed | NCOA3 NOL4 MYCBP2 AIMP1 INPP4A RBBP8NL GTF3C4 ALMS1 ZNF608 UBR5 TACC3 MGA WDR62 TCF20 NCOR2 KMT2D LRP2 GIGYF2 CNOT1 | 7.17e-11 | 418 | 232 | 19 | 34709266 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NCOA3 INTU CAND2 MYO5B MYCBP2 AIMP1 PSMD13 GTF3C4 DDX1 MKS1 DOCK5 AP2M1 NF1 BBX AIPL1 HELZ KIF3C MOV10 WDR62 DNM2 EXOC6 CRTC3 MYO19 SMC4 AMBRA1 PCARE KIFAP3 MTOR BBS7 GIGYF2 STARD3NL FGD6 CNOT1 | 7.56e-11 | 1321 | 232 | 33 | 27173435 |
| Pubmed | MYO1D MYCBP2 PABPC4 PGK1 WDR43 WDR3 NF1 UBR5 HELZ PHIP MOV10 DNM2 KIF23 TCF20 SMC4 CCT2 FRYL PABPC1 UTP25 MTOR GIGYF2 SPEN CNOT1 | 1.10e-10 | 653 | 232 | 23 | 22586326 | |
| Pubmed | 2.28e-10 | 83 | 232 | 10 | 28794006 | ||
| Pubmed | CDK9 ILK ZSWIM3 UBE4B INPP4A HSD11B1L EMSY WDR43 MED24 RBSN NOD1 NF1 UBR5 UBP1 PHLPP1 HELZ HCFC2 MGA QSOX2 HJV KIF23 BICRA MAU2 PAPSS2 PAPSS1 LDLR ARNT TKT PAXIP1 GIGYF2 MAML2 CNOT1 | 3.64e-10 | 1327 | 232 | 32 | 32694731 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 NCOA6 ERG UBE4B MYCBP2 TBC1D2 ZFPM1 GTF3C4 EMSY MED24 NF1 HELZ TACC3 KDM6A WDR62 DNM2 KIF23 TCF20 NCOR2 KMT2D TKT GIGYF2 SPEN CYTH4 | 5.50e-10 | 774 | 232 | 24 | 15302935 |
| Pubmed | CDK9 NOL4 INTU ZZEF1 HMCN2 ALMS1 ZNF608 ZNRF3 UBR5 MLLT1 HELZ MCRS1 MGA PHIP QSOX2 WDR62 BICRA KAT6A AMBRA1 LDLR TRIM33 CCNT1 NCOR2 UTP25 EHMT1 LRP2 BICRAL USP54 | 2.14e-09 | 1116 | 232 | 28 | 31753913 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ILK UBE4B MYCBP2 PSMD13 PGK1 GTF3C4 DDX1 HIRA WDR3 AP2M1 PTPN12 NF1 UBR5 MGA PHIP MOV10 CUL1 FNDC3B KIF23 TCF20 MYO19 SMC4 AMBRA1 CCT2 PAPSS2 PABPC1 CCNT1 NCOR2 GTF2H4 TKT CTNND1 | 2.38e-09 | 1353 | 232 | 31 | 29467282 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DACH1 GTF3C4 EMSY HIRA BBX AARS2 UBR5 UBP1 MCRS1 MGA NOTCH1 ANKRD26P1 MOV10 CUL1 SMC4 POU2F2 SIX1 TRIM33 NCOR2 FOXD3 ARNT KMT2D CTNND1 SPEN | 4.04e-09 | 857 | 232 | 24 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK9 DDX19B NCOA6 ILK MYCBP2 RPS6KA2 DDX1 RBSN NF1 ALMS1 HELZ WDR62 CRTC3 KIF23 SH3RF1 TCF20 GRB10 FRYL PABPC1 MTOR GIGYF2 USP54 CTNND1 FGD6 | 4.42e-09 | 861 | 232 | 24 | 36931259 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | TTLL5 TBC1D2 ALMS1 UBR5 MGA NOTCH1 LDLR TRIM33 NCOR2 KMT2D GIGYF2 SPEN | 4.64e-09 | 184 | 232 | 12 | 32908313 |
| Pubmed | CDK9 NCOA3 PSMD13 PGK1 GTF3C4 DDX1 WDR3 MED24 AP2M1 UBR5 KDM6A CUL1 KIF23 TCF20 SMC4 CCT2 MAU2 SIRT6 PAPSS1 THOC5 TRIM33 CCNT1 NCOR2 TKT EHMT1 CTNND1 | 5.40e-09 | 1014 | 232 | 26 | 32416067 | |
| Pubmed | PABPC4 ZZEF1 SPTBN5 ALMS1 SCN1A HELZ DMD DNAH8 IGSF3 CCT2 PABPC1 CELSR3 | 5.57e-09 | 187 | 232 | 12 | 26460568 | |
| Pubmed | BCL9L NCOA3 PABPC4 GTF3C4 WDR43 PTPN12 ALMS1 KDM6A PHIP MOV10 SMC4 PLCD4 TRIM33 KMT2D EHMT1 SPEN CNOT1 | 2.14e-08 | 469 | 232 | 17 | 27634302 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA3 ERG PGK1 GTF3C4 DDX1 KDM6A TCF20 TRIM33 NCOR2 ARNT KMT2D TKT | 3.41e-08 | 220 | 232 | 12 | 35785414 |
| Pubmed | NCOA3 MYCBP2 CYTH2 RPS6KA2 TENM2 PGK1 EMSY HIRA MAGI2 NF1 UBR5 LRRC7 TACC3 MGA DNM2 KIF23 TCF20 PABPC1 NCOR2 MTOR EHMT1 GIGYF2 CTNND1 CNOT1 | 3.71e-08 | 963 | 232 | 24 | 28671696 | |
| Pubmed | NCOA6 MYCBP2 DACH1 GTF3C4 EMSY ALMS1 TACC3 MGA KDM6A KIF23 TCF20 SMC4 CCT2 KMT2D GIGYF2 CTNND1 SPEN CNOT1 | 3.75e-08 | 549 | 232 | 18 | 38280479 | |
| Pubmed | 4.20e-08 | 50 | 232 | 7 | 37974198 | ||
| Pubmed | 6.65e-08 | 7 | 232 | 4 | 12665583 | ||
| Pubmed | 1.32e-07 | 8 | 232 | 4 | 17178841 | ||
| Pubmed | 1.32e-07 | 8 | 232 | 4 | 36135776 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MYCBP2 AIMP1 PABPC4 FZD1 MAGI2 HELZ PHIP NOTCH1 MOV10 SIRT6 SIX1 PABPC1 MTOR CNOT1 | 1.55e-07 | 358 | 232 | 14 | 32460013 |
| Pubmed | 2.45e-07 | 130 | 232 | 9 | 12421765 | ||
| Pubmed | 2.69e-07 | 65 | 232 | 7 | 22496869 | ||
| Pubmed | 2.93e-07 | 3 | 232 | 3 | 11245412 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 3.04e-07 | 22 | 232 | 5 | 26886794 | |
| Pubmed | CDK9 DDX19B NCOA6 MYO1D MYO5B PABPC4 PSMD13 PGK1 DDX1 AP2M1 ZNF608 MLLT1 MGA DNM2 CUL1 KIF23 SMC4 CCT2 PAPSS1 PABPC1 THOC5 CCNT1 NCOR2 ARNT RNF6 CTNND1 | 3.19e-07 | 1247 | 232 | 26 | 27684187 | |
| Pubmed | PABPC4 PGK1 MKS1 DOCK5 WDR3 MET RBSN BBX UBR5 HCFC2 TACC3 MGA IGSF3 KIF23 MUC16 CCT2 TRIM33 EHMT1 CTNND1 SPEN | 3.24e-07 | 777 | 232 | 20 | 35844135 | |
| Pubmed | EMSY AP2M1 MLLT1 MGA KIF23 TCF20 AFF3 ZBTB12 TRIM33 CCNT1 PAXIP1 | 3.36e-07 | 222 | 232 | 11 | 37071664 | |
| Pubmed | 3.86e-07 | 23 | 232 | 5 | 9225980 | ||
| Pubmed | PSMD13 GTF3C4 PTPN12 UBR5 TRPM1 TCF20 PCLO SMC4 MUC16 TRIM33 NCOR2 TKT PAXIP1 SPEN | 5.23e-07 | 396 | 232 | 14 | 26687479 | |
| Pubmed | NCOA6 MYCBP2 INPP4A PABPC4 ZZEF1 PTPN12 UBR5 MGA KDM6A DNM2 RARB LAMA5 NCOR2 ARNT KMT2D PAXIP1 POLI | 5.67e-07 | 591 | 232 | 17 | 15231748 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 UBE4B ESRP1 EMSY HIRA WDR3 MED24 TCF20 SMC4 CCNT1 KMT2D PAXIP1 SPEN | 5.79e-07 | 341 | 232 | 13 | 32971831 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 GTF3C4 EMSY WDR43 HIRA DOCK5 WDR3 BBX UBP1 MLLT1 MCRS1 HCFC2 MGA KDM6A CUL1 KIF23 TCF20 MAU2 LDLR THOC5 NCOR2 ARNT KMT2D PAXIP1 EHMT1 SPEN | 6.40e-07 | 1294 | 232 | 26 | 30804502 |
| Pubmed | BCL9L MYCBP2 AIMP1 PDK1 PDK2 PDK3 CYTH2 PSMD13 TENM2 PGK1 MAGI2 MET RBSN AP2M1 NF1 SCN1A HELZ LRRC7 IGSF3 PCLO ADGRL1 CPNE4 CTNND1 CNOT1 | 7.77e-07 | 1139 | 232 | 24 | 36417873 | |
| Pubmed | 7.93e-07 | 110 | 232 | 8 | 25940091 | ||
| Pubmed | 8.69e-07 | 151 | 232 | 9 | 17043677 | ||
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 30482839 | ||
| Pubmed | Differing roles of pyruvate dehydrogenase kinases during mouse oocyte maturation. | 1.17e-06 | 4 | 232 | 3 | 25991547 | |
| Pubmed | Diversity of the pyruvate dehydrogenase kinase gene family in humans. | 1.17e-06 | 4 | 232 | 3 | 7499431 | |
| Pubmed | HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold. | 1.17e-06 | 4 | 232 | 3 | 23251033 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 1.32e-06 | 13 | 232 | 4 | 17761849 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYO5B MYCBP2 TTLL5 AP2M1 NF1 ZNRF3 UBP1 MLLT1 MCRS1 TACC3 NOTCH1 DNM2 RBM45 LAMA5 ADGRL1 FRYL | 1.34e-06 | 560 | 232 | 16 | 21653829 |
| Pubmed | PDK1 ECD PSMD13 GTF3C4 WDR3 MED24 AP2M1 AARS2 DNM2 CUL1 SMC4 THOC5 TRIM33 GTF2H4 EHMT1 CNOT1 | 1.34e-06 | 560 | 232 | 16 | 35241646 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 DOCK5 SCN1A MGA NOTCH1 CRTC3 BICRA MAU2 PABPC1 NCOR2 TP63 IGSF9B MAML2 SPEN | 1.38e-06 | 430 | 232 | 14 | 35044719 |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | LYPD6 ERG TBC1D2 EMSY WDR43 BBX ZNRF3 HELZ PHIP MAU2 ARNT TKT PAM CYTH4 | 1.42e-06 | 431 | 232 | 14 | 33660365 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | CDK9 CAND2 MYO1D ECD PSMD13 NF1 DMD SMC4 LAMA5 CCNT1 CTNND1 SPEN | 1.49e-06 | 313 | 232 | 12 | 38270169 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D MYO5B MYCBP2 PABPC4 PGK1 DDX1 WDR43 WDR3 NF1 AARS2 UBR5 MGA PHIP TCF20 SMC4 CCT2 PABPC1 BBS7 GIGYF2 CTNND1 SPEN CNOT1 | 1.68e-06 | 1024 | 232 | 22 | 24711643 |
| Pubmed | 1.83e-06 | 14 | 232 | 4 | 20854876 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 PABPC4 DACH1 EMSY DDX1 WDR43 WDR3 BBX MLLT1 MGA PHIP KIF23 RARA TCF20 BICRA PABPC1 TRIM33 CCNT1 NCOR2 GIGYF2 SPEN | 2.00e-06 | 954 | 232 | 21 | 36373674 |
| Pubmed | BCL9L GTF3C4 NF1 ALMS1 UBR5 HELZ NOTCH1 WDR62 CRTC3 SH3RF1 FRYL GIGYF2 USP54 CNOT1 | 2.12e-06 | 446 | 232 | 14 | 24255178 | |
| Pubmed | 2.26e-06 | 57 | 232 | 6 | 18022353 | ||
| Pubmed | 2.49e-06 | 15 | 232 | 4 | 17925232 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 2.49e-06 | 15 | 232 | 4 | 31285543 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | INTU UBE4B MYCBP2 AIMP1 INPP4A RPS6KA2 TMEM212 RBBP8NL TTC19 DOCK5 ZNF608 LRRC7 KDM6A BICRA KAT6A AFF3 GRB10 ADGRL1 GRIK1 FRYL NCOR2 GPR137C EHMT1 IGSF9B CTNND1 CNOT1 VPS13B | 2.69e-06 | 1489 | 232 | 27 | 28611215 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA3 NCOA6 DDX1 HELZ CUL1 FNDC3B CRTC3 TCF20 TRIM33 NCOR2 ARNT KMT2D CNOT1 | 2.81e-06 | 457 | 232 | 14 | 32344865 |
| Pubmed | 2.90e-06 | 5 | 232 | 3 | 11978179 | ||
| Pubmed | 2.90e-06 | 5 | 232 | 3 | 11486000 | ||
| Pubmed | Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites. | 2.90e-06 | 5 | 232 | 3 | 11485553 | |
| Pubmed | 3.24e-06 | 177 | 232 | 9 | 26206133 | ||
| Pubmed | 3.30e-06 | 16 | 232 | 4 | 24368734 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 3.33e-06 | 133 | 232 | 8 | 15604093 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CDK9 ILK RPS6KA2 GTF3C4 MET AP2M1 PTPN12 NF1 MLLT1 DNM2 CUL1 IL31RA NLRX1 AFF3 CCNT1 NCOR2 GTF2H4 UTP25 IGSF9B CTNND1 | 3.63e-06 | 910 | 232 | 20 | 36736316 |
| Pubmed | DDX19B CAND2 MYCBP2 PSMD13 GTF3C4 AARS2 WDR62 DNM2 EXOC6 MYO19 NLRX1 AMBRA1 MTOR BBS7 USP54 CTNND1 | 3.68e-06 | 606 | 232 | 16 | 36538041 | |
| Pubmed | MYO1D MYO5B PDK1 INPP4A CYTH2 PABPC4 PGK1 DDX1 MAGI2 AP2M1 NF1 C4B LRRC7 DMD CNTN2 DNM2 MICAL1 PCLO ADGRL1 CCT2 PABPC1 TKT USP54 CPNE4 CTNND1 CNOT1 | 4.03e-06 | 1431 | 232 | 26 | 37142655 | |
| Pubmed | INTU UBE4B TENM2 ADCY2 MAGI2 UBR5 LRRC7 TCF20 GRB10 ADGRL1 GIGYF2 SPEN VPS13B | 4.08e-06 | 407 | 232 | 13 | 12693553 | |
| Pubmed | 4.29e-06 | 17 | 232 | 4 | 26180087 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | HIRA WDR3 MED24 NF1 BBX AARS2 MGA MOV10 GRB10 THOC5 CCNT1 KMT2D SPEN | 4.41e-06 | 410 | 232 | 13 | 26949251 |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 5.49e-06 | 18 | 232 | 4 | 17500065 | |
| Pubmed | 5.77e-06 | 6 | 232 | 3 | 11689688 | ||
| Pubmed | 5.77e-06 | 6 | 232 | 3 | 11929748 | ||
| Pubmed | Misguided transcriptional elongation causes mixed lineage leukemia. | 5.77e-06 | 6 | 232 | 3 | 19956800 | |
| Pubmed | BCKDK regulates the TCA cycle through PDC in the absence of PDK family during embryonic development. | 5.77e-06 | 6 | 232 | 3 | 33773101 | |
| Pubmed | 5.79e-06 | 102 | 232 | 7 | 26584622 | ||
| Pubmed | 6.31e-06 | 244 | 232 | 10 | 29884807 | ||
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 6.40e-06 | 68 | 232 | 6 | 25754235 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NCOA3 ECD PABPC4 MKS1 WDR43 HROB AP2M1 UBR5 UBP1 MCRS1 DMD CRTC3 GRB10 PABPC1 TRIM33 MTOR TMED8 PAXIP1 GIGYF2 CTNND1 CNOT1 | 7.32e-06 | 1038 | 232 | 21 | 26673895 |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 8.24e-06 | 71 | 232 | 6 | 28319113 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO1D MYCBP2 PABPC4 HIRA HELZ MGA MOV10 FNDC3B PABPC1 THOC5 GTF2H4 TKT EHMT1 GIGYF2 CTNND1 SPEN CNOT1 | 8.54e-06 | 724 | 232 | 17 | 36232890 |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 8.60e-06 | 20 | 232 | 4 | 29785026 | |
| Pubmed | 8.60e-06 | 20 | 232 | 4 | 19047629 | ||
| Pubmed | FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. | 8.60e-06 | 20 | 232 | 4 | 32350066 | |
| Pubmed | 8.93e-06 | 152 | 232 | 8 | 38360978 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 8.98e-06 | 109 | 232 | 7 | 33554859 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYCBP2 PSMD13 ZZEF1 PGK1 GTF3C4 DDX1 AP2M1 SLC13A4 PDLIM3 DNM2 CUL1 PCLO ZNF805 CCT2 PAPSS2 PABPC1 TKT CNOT1 | 9.27e-06 | 807 | 232 | 18 | 30575818 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MYCBP2 GTF3C4 WDR3 NF1 UBR5 MOV10 KIF23 AMBRA1 SIRT6 GTF2H4 UTP25 USP54 CTNND1 | 9.40e-06 | 440 | 232 | 13 | 34244565 |
| Pubmed | NCOA3 AIMP1 PABPC4 GTF3C4 BBX UBR5 HELZ MOV10 CUL1 CRTC3 AMBRA1 PABPC1 NCOR2 GIGYF2 USP54 CTNND1 | 9.73e-06 | 655 | 232 | 16 | 35819319 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CDK9 DDX19B ILK PSMD13 DDX1 DOCK5 NF1 DNM2 CUL1 RBM45 SMC4 CCT2 NCOR2 CTNND1 CNOT1 | 9.91e-06 | 582 | 232 | 15 | 20467437 |
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 10449983 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ECD PABPC4 PGK1 GTF3C4 WDR43 AP2M1 UBR5 MCRS1 TACC3 MOV10 WDR62 KIF23 AMBRA1 CCT2 MAU2 PAPSS2 PAPSS1 PABPC1 TKT EHMT1 CNOT1 VPS13B | 1.13e-05 | 1155 | 232 | 22 | 20360068 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYO1D AIMP1 PABPC4 PSMD13 PGK1 DDX1 WDR43 WDR3 AP2M1 NF1 KIF3C PHIP CUL1 KIF23 PCLO SMC4 CCT2 PABPC1 MTOR TKT EHMT1 GIGYF2 CTNND1 SPEN CNOT1 | 1.13e-05 | 1425 | 232 | 25 | 30948266 |
| Pubmed | ALMS1 HELZ LRRC7 SH3RF1 TCF20 GIGYF2 USP54 CTNND1 CNOT1 VPS13B | 1.21e-05 | 263 | 232 | 10 | 34702444 | |
| Pubmed | PSMD13 GTF3C4 EMSY HIRA UBR5 MGA KIF23 TCF20 RBM45 MAU2 TRIM33 GTF2H4 RNF6 | 1.28e-05 | 453 | 232 | 13 | 29656893 | |
| Interaction | HNF4A interactions | NCOA3 NCOA6 PABPC4 DACH1 EMSY HIRA MED24 ZNF608 MCRS1 DMD MGA KDM6A BICRA TRIM33 NCOR2 ARNT KMT2D PAXIP1 EHMT1 SPEN | 4.61e-11 | 275 | 227 | 20 | int:HNF4A |
| Interaction | SETD1B interactions | CDK9 NCOA6 ZNF608 MCRS1 HCFC2 KDM6A SIRT6 LDLR KMT2D TP63 PAXIP1 | 7.56e-10 | 75 | 227 | 11 | int:SETD1B |
| Interaction | AR interactions | CDK9 BCL9L NCOA3 NCOA6 ERG MYO1D MYO5B MYCBP2 DTX3L PSMD13 PGK1 GTF3C4 EMSY DDX1 HIRA MED24 ZNF608 UBR5 MCRS1 MGA KDM6A TCF20 POU2F2 PABPC1 TRIM33 KIFAP3 CCNT1 NCOR2 ARNT KMT2D RNF6 TKT PAXIP1 USP54 | 6.79e-09 | 992 | 227 | 34 | int:AR |
| Interaction | EGR2 interactions | BCL9L NCOA3 NCOA6 EMSY HIRA ZNF608 MCRS1 MGA KDM6A BICRA TRIM33 NCOR2 KMT2D PAXIP1 | 9.03e-09 | 171 | 227 | 14 | int:EGR2 |
| Interaction | CRX interactions | BCL9L NCOA3 HIRA ZNF608 MGA KDM6A TCF20 BICRA ZIC1 TRIM33 NCOR2 ARNT KMT2D PAXIP1 EHMT1 SPEN | 3.28e-08 | 254 | 227 | 16 | int:CRX |
| Interaction | TOP3B interactions | CDK9 DDX19B NCOA6 MYO1D UBE4B MYCBP2 AIMP1 RPS6KA2 ZFPM1 ZZEF1 HIRA FZD1 ZNRF3 MLLT1 HELZ NOTCH1 MOV10 IGSF3 KIF23 SH3RF1 BICRA NLRX1 KAT6A LAMA5 GRB10 AMBRA1 ADGRL1 FRYL PABPC1 LDLR NCOR2 KMT2D CELSR3 MTOR TMEM268 PAXIP1 EHMT1 IL17RD SPEN CNOT1 CYTH4 | 5.66e-08 | 1470 | 227 | 41 | int:TOP3B |
| Interaction | CEBPA interactions | CDK9 DDX19B NCOA3 NCOA6 ILK MYCBP2 PABPC4 DACH1 PGK1 EMSY DDX1 MED24 AP2M1 UBR5 KDM6A DNM2 CUL1 RARA RARB TCF20 BICRA SMC4 CCT2 PABPC1 THOC5 TRIM33 CCNT1 NCOR2 ARNT KMT2D TKT PAXIP1 EHMT1 BICRAL SPEN CNOT1 MYB | 5.72e-08 | 1245 | 227 | 37 | int:CEBPA |
| Interaction | PARP1 interactions | CDK9 NCOA6 ERG MYO5B MYCBP2 ECD DACH1 DTX3L PGK1 WDR43 WDR3 MED24 BBX UBP1 BTN1A1 MLLT1 MGA PHIP NOTCH1 MOV10 DNM2 CUL1 FNDC3B KIF23 RARA RARB RBM45 BICRA SMC4 PELI1 SIRT6 PAPSS2 PAPSS1 LDLR TRIM33 MTOR EHMT1 MYB | 7.77e-08 | 1316 | 227 | 38 | int:PARP1 |
| Interaction | FEV interactions | NCOA3 NCOA6 DACH1 EMSY ZNF608 MGA KDM6A TCF20 BICRA NCOR2 ARNT KMT2D PAXIP1 EHMT1 | 7.93e-08 | 203 | 227 | 14 | int:FEV |
| Interaction | HCFC2 interactions | 8.68e-08 | 92 | 227 | 10 | int:HCFC2 | |
| Interaction | ELF5 interactions | GTF3C4 EMSY HIRA UBP1 KDM6A CCT2 SIRT6 TRIM33 KMT2D PAXIP1 EHMT1 CTNND1 | 1.10e-07 | 147 | 227 | 12 | int:ELF5 |
| Interaction | MEN1 interactions | CDK9 NCOA6 UBE4B PABPC4 ESRP1 GTF3C4 EMSY DDX1 HIRA WDR3 MED24 ZNF608 UBR5 MCRS1 HCFC2 KDM6A MOV10 WDR62 CUL1 KIF23 TCF20 SMC4 LAMA5 PABPC1 CCNT1 KMT2D PAXIP1 EHMT1 GIGYF2 CTNND1 SPEN MYB | 1.85e-07 | 1029 | 227 | 32 | int:MEN1 |
| Interaction | SP7 interactions | BCL9L NCOA3 NCOA6 ZNF608 MLLT1 MGA KDM6A CUL1 TCF20 BICRA TRIM33 NCOR2 ARNT KMT2D PAXIP1 EHMT1 | 3.84e-07 | 304 | 227 | 16 | int:SP7 |
| Interaction | POU5F1 interactions | ILK PSMD13 GTF3C4 EMSY HIRA AP2M1 UBR5 UBP1 HELZ TRPM1 MGA TCF20 SMC4 MUC16 CCT2 SIRT6 TRIM33 NCOR2 FOXD3 PAXIP1 GIGYF2 CNOT1 | 8.23e-07 | 584 | 227 | 22 | int:POU5F1 |
| Interaction | ASF1A interactions | NCOA6 EMSY HIRA MGA CUL1 KIF23 TCF20 BICRA TRIM33 CCNT1 NCOR2 ARNT KMT2D SPEN | 9.56e-07 | 249 | 227 | 14 | int:ASF1A |
| Interaction | TLE3 interactions | BCL9L NCOA3 ERG EMSY ZNF608 UBR5 HELZ NOTCH1 CRTC3 TCF20 SIX1 SIX3 NCOR2 ARNT KMT2D RNF6 SPEN | 1.37e-06 | 376 | 227 | 17 | int:TLE3 |
| Interaction | ERG interactions | NCOA3 NCOA6 ERG EMSY ZNF608 UBR5 KDM6A TCF20 BICRA TRIM33 NCOR2 KMT2D PAXIP1 | 1.57e-06 | 223 | 227 | 13 | int:ERG |
| Interaction | INTU interactions | 1.59e-06 | 51 | 227 | 7 | int:INTU | |
| Interaction | AKT1 interactions | NOL4 ILK PDK1 PDK2 EMSY NF1 UBR5 PHLPP1 NOTCH1 CUL1 RARA SH3RF1 KAT6A GRB10 AMBRA1 CCT2 SIRT6 NCOR2 ARNT KMT2D MTOR CTNND1 | 2.03e-06 | 617 | 227 | 22 | int:AKT1 |
| Interaction | FASN interactions | CDK9 ILK ZSWIM3 AIMP1 INPP4A PSMD13 HSD11B1L EMSY WDR43 AP2M1 NF1 UBP1 PHLPP1 HELZ HCFC2 MGA KIF23 RBM45 BICRA MAU2 PAPSS2 PAPSS1 PABPC1 LDLR TRIM33 ARNT PAXIP1 GIGYF2 MAML2 CNOT1 | 3.34e-06 | 1062 | 227 | 30 | int:FASN |
| Interaction | SMG7 interactions | NCOA3 NCOA6 DACH1 PSMD13 ZNF608 HELZ PHIP MOV10 TCF20 PABPC1 NCOR2 ARNT KMT2D PAXIP1 CNOT1 | 3.61e-06 | 319 | 227 | 15 | int:SMG7 |
| Interaction | SIRT7 interactions | CDK9 MYO1D MYCBP2 PABPC4 PGK1 WDR43 WDR3 NF1 UBR5 HELZ PHIP MOV10 DNM2 KIF23 TCF20 SMC4 CCT2 FRYL PABPC1 UTP25 MTOR GIGYF2 SPEN CNOT1 | 3.87e-06 | 744 | 227 | 24 | int:SIRT7 |
| Interaction | SOX7 interactions | 3.99e-06 | 82 | 227 | 8 | int:SOX7 | |
| Interaction | PAX2 interactions | 5.23e-06 | 85 | 227 | 8 | int:PAX2 | |
| Interaction | GSC interactions | 6.23e-06 | 87 | 227 | 8 | int:GSC | |
| Interaction | TBXT interactions | 6.68e-06 | 116 | 227 | 9 | int:TBXT | |
| Interaction | KDM1A interactions | NCOA3 NOL4 MYCBP2 AIMP1 INPP4A ZFPM1 RBBP8NL GTF3C4 DDX1 AP2M1 ALMS1 ZNF608 UBR5 MCRS1 TACC3 MGA NOTCH1 WDR62 TCF20 SIRT6 NCOR2 KMT2D GTF2H4 EHMT1 LRP2 GIGYF2 CNOT1 | 8.15e-06 | 941 | 227 | 27 | int:KDM1A |
| Interaction | FXR1 interactions | MYO5B MYCBP2 TTLL5 PABPC4 DDX1 AP2M1 UBP1 MLLT1 HELZ MCRS1 TRPM1 DNM2 CUL1 KIF23 RBM45 GRB10 SIRT6 PABPC1 LDLR NCOR2 GIGYF2 CNOT1 | 9.35e-06 | 679 | 227 | 22 | int:FXR1 |
| Interaction | NANOG interactions | GTF3C4 EMSY DDX1 HIRA PTPN12 TRPM1 MGA MOV10 TCF20 MUC16 PABPC1 THOC5 TRIM33 NCOR2 ARNT PAXIP1 EHMT1 CNOT1 | 9.37e-06 | 481 | 227 | 18 | int:NANOG |
| Interaction | FOXI1 interactions | 9.46e-06 | 92 | 227 | 8 | int:FOXI1 | |
| Interaction | ASH2L interactions | NCOA6 EMSY UBR5 MCRS1 HCFC2 MGA KDM6A SIRT6 LDLR SPRYD7 KMT2D PAXIP1 MYB | 1.04e-05 | 265 | 227 | 13 | int:ASH2L |
| Interaction | HNF1B interactions | NCOA3 DACH1 HIRA ZNF608 MGA KDM6A BICRA NCOR2 KMT2D PAXIP1 USP54 | 1.08e-05 | 190 | 227 | 11 | int:HNF1B |
| Interaction | NFIX interactions | DACH1 EMSY ZNF608 MCRS1 MGA KDM6A BICRA NCOR2 KMT2D PAXIP1 EHMT1 SPEN | 1.08e-05 | 227 | 227 | 12 | int:NFIX |
| Interaction | PAX7 interactions | 1.15e-05 | 124 | 227 | 9 | int:PAX7 | |
| Interaction | SOX17 interactions | 1.20e-05 | 95 | 227 | 8 | int:SOX17 | |
| Interaction | ETV4 interactions | 1.25e-05 | 69 | 227 | 7 | int:ETV4 | |
| Interaction | FOS interactions | NCOA3 NCOA6 MYO1D RPS6KA2 HIRA MGA KDM6A CABP1 TRIM33 NCOR2 ARNT KMT2D PAXIP1 CYTH4 | 1.30e-05 | 312 | 227 | 14 | int:FOS |
| Interaction | KMT2A interactions | CDK9 NCOA6 ZNF608 MLLT1 MCRS1 HCFC2 DNAH8 KDM6A KAT6A LDLR CCNT1 KMT2D PAXIP1 MYB | 1.40e-05 | 314 | 227 | 14 | int:KMT2A |
| Interaction | NR3C1 interactions | DDX19B NCOA3 NCOA6 MYO1D AIMP1 ECD ADCY2 NF1 UBP1 MCRS1 KDM6A IGSF3 DNM2 EXOC6 RARB TCF20 MUC16 POU2F2 NCOR2 KMT2D RNF6 BBS7 PAXIP1 EHMT1 IL17RD SPEN CNOT1 | 1.51e-05 | 974 | 227 | 27 | int:NR3C1 |
| Interaction | CREBBP interactions | CDK9 NCOA3 NCOA6 ERG RPS6KA2 DACH1 HELZ MGA KDM6A CNTN2 RARA KAT6A SIRT6 LDLR TRIM33 NCOR2 ARNT KMT2D MAML2 MYB | 1.58e-05 | 599 | 227 | 20 | int:CREBBP |
| Interaction | GATA2 interactions | NCOA3 NCOA6 ZFPM1 ZNF608 KDM6A CUL1 RARA NCOR2 KMT2D PAXIP1 EHMT1 | 1.67e-05 | 199 | 227 | 11 | int:GATA2 |
| Interaction | PAX9 interactions | 1.68e-05 | 130 | 227 | 9 | int:PAX9 | |
| Interaction | CXXC1 interactions | 1.90e-05 | 132 | 227 | 9 | int:CXXC1 | |
| Interaction | RUNX1 interactions | CDK9 PABPC4 DDX1 UBP1 MLLT1 NOTCH1 RARA KAT6A PABPC1 TRIM33 NCOR2 TKT PAXIP1 SPEN | 1.98e-05 | 324 | 227 | 14 | int:RUNX1 |
| Interaction | GUSBP5 interactions | 2.17e-05 | 75 | 227 | 7 | int:GUSBP5 | |
| Interaction | CCT4 interactions | CDK9 ILK MYCBP2 PDK1 PDK3 MKS1 STRADB FBXO25 UBR5 PHLPP1 HCFC2 CUL1 KIF23 MYO19 LAMA5 AMBRA1 CCT2 CAPN10 | 2.34e-05 | 515 | 227 | 18 | int:CCT4 |
| Interaction | SOX2 interactions | BCL9L NCOA3 NCOA6 ILK ERG AIMP1 PABPC4 DACH1 PGK1 DDX1 HIRA WDR3 AP2M1 ZNF608 UBR5 MLLT1 HELZ KDM6A KIF23 TCF20 CCT2 SIX1 TRIM33 CCNT1 NCOR2 ARNT KMT2D TKT TP63 PAXIP1 EHMT1 CTNND1 SPEN CNOT1 | 2.50e-05 | 1422 | 227 | 34 | int:SOX2 |
| Interaction | NUP35 interactions | CDK9 DDX19B BCL9L NCOA3 NCOA6 DDX1 HELZ FNDC3B CRTC3 TCF20 SIRT6 TRIM33 NCOR2 ARNT KMT2D CNOT1 | 2.69e-05 | 424 | 227 | 16 | int:NUP35 |
| Interaction | CTNNB1 interactions | CDK9 BCL9L ILK MYO5B PABPC4 PGK1 DDX1 MKS1 MAGI2 MET AP2M1 UBR5 NOTCH1 MOV10 CUL1 KIF23 GRB10 CCT2 SIRT6 PABPC1 TRIM33 KIFAP3 ARNT KMT2D RNF6 USP54 CTNND1 | 2.80e-05 | 1009 | 227 | 27 | int:CTNNB1 |
| Interaction | NUP43 interactions | BCL9L NCOA6 CCDC168 EMSY WDR43 WDR3 BBX ZNF608 UBR5 HCFC2 MGA PHIP TCF20 CCT2 SIRT6 NCOR2 KMT2D EHMT1 SPEN CNOT1 | 2.89e-05 | 625 | 227 | 20 | int:NUP43 |
| Interaction | RNF43 interactions | PABPC4 PSMD13 ALMS1 ZNRF3 UBR5 HELZ LRRC7 MOV10 DNM2 SH3RF1 TCF20 GIGYF2 USP54 CTNND1 CNOT1 VPS13B | 2.92e-05 | 427 | 227 | 16 | int:RNF43 |
| Interaction | RUVBL1 interactions | CDK9 ILK ECD HIRA FBXO25 UBR5 PHLPP1 MCRS1 MGA CUL1 KIF23 RARA SMC4 MAU2 SIRT6 PABPC1 ARNT MTOR CDHR4 | 2.98e-05 | 575 | 227 | 19 | int:RUVBL1 |
| Interaction | TLX1 interactions | NCOA3 DACH1 ZNF608 KDM6A TCF20 KAT6A NCOR2 KMT2D PAXIP1 EHMT1 | 3.05e-05 | 175 | 227 | 10 | int:TLX1 |
| Interaction | GAN interactions | PABPC4 ZZEF1 SPTBN5 ALMS1 SCN1A HELZ DMD DNAH8 IGSF3 CCT2 PABPC1 CELSR3 | 3.17e-05 | 253 | 227 | 12 | int:GAN |
| Interaction | TEAD1 interactions | 3.21e-05 | 176 | 227 | 10 | int:TEAD1 | |
| Interaction | RPTOR interactions | INTU UBE4B PDK1 PABPC4 DDX1 UBR5 HELZ MOV10 AMBRA1 CCT2 PABPC1 MTOR TKT CNOT1 | 3.47e-05 | 341 | 227 | 14 | int:RPTOR |
| Interaction | EN1 interactions | 3.50e-05 | 110 | 227 | 8 | int:EN1 | |
| Interaction | TP53BP1 interactions | NCOA3 NCOA6 PSMD13 GTF3C4 EMSY HIRA UBR5 MGA MOV10 IGSF3 PELI1 MAU2 SIRT6 TRIM33 KIFAP3 CCNT1 GTF2H4 PAXIP1 | 3.66e-05 | 533 | 227 | 18 | int:TP53BP1 |
| Interaction | BCOR interactions | ERG RPS6KA2 EMSY ZNF608 MLLT1 TRPM1 MGA PHIP SMC4 SIRT6 NCOR2 TKT CPNE4 | 4.09e-05 | 302 | 227 | 13 | int:BCOR |
| Interaction | PAIP1 interactions | 4.23e-05 | 146 | 227 | 9 | int:PAIP1 | |
| Interaction | TBR1 interactions | 4.25e-05 | 113 | 227 | 8 | int:TBR1 | |
| Interaction | YAP1 interactions | BCL9L NCOA6 MYO1D DACH1 PSMD13 PGK1 GTF3C4 DDX1 NF1 SCN1A TUBA4B MGA KDM6A MOV10 CRTC3 TCF20 SMC4 CCT2 PABPC1 ARNT KMT2D TKT TP63 GIGYF2 IGSF9B CTNND1 SPEN CNOT1 | 4.41e-05 | 1095 | 227 | 28 | int:YAP1 |
| Interaction | RNF2 interactions | NCOA6 ERG PABPC4 ESRP1 GTF3C4 EMSY WDR43 MED24 AARS2 UBR5 MLLT1 HELZ MGA KDM6A PHIP NOTCH1 MOV10 PCLO SMC4 AMBRA1 THOC5 KMT2D PAXIP1 EHMT1 | 4.65e-05 | 866 | 227 | 24 | int:RNF2 |
| Interaction | RARA interactions | NCOA3 NCOA6 DDX1 AP2M1 MCRS1 RARA RARB PABPC1 NCOR2 SPEN CNOT1 | 4.76e-05 | 223 | 227 | 11 | int:RARA |
| Interaction | MIF interactions | NCOA3 PDK3 PGK1 NF1 UBR5 TCF20 RBM45 PABPC1 LDLR TKT GIGYF2 CTNND1 | 4.80e-05 | 264 | 227 | 12 | int:MIF |
| Interaction | AFF4 interactions | 4.82e-05 | 115 | 227 | 8 | int:AFF4 | |
| Interaction | PPARG interactions | NCOA3 NCOA6 MED24 UBR5 KDM6A RARA BICRA SIRT6 NCOR2 KMT2D PAXIP1 GIGYF2 CNOT1 | 4.84e-05 | 307 | 227 | 13 | int:PPARG |
| Interaction | IRF4 interactions | 4.91e-05 | 85 | 227 | 7 | int:IRF4 | |
| Interaction | PPP4R1L interactions | 5.71e-05 | 87 | 227 | 7 | int:PPP4R1L | |
| Interaction | TNS3 interactions | 5.71e-05 | 87 | 227 | 7 | int:TNS3 | |
| Interaction | DVL2 interactions | DDX19B BCL9L PDK3 PSMD13 AP2M1 ZNRF3 PHLPP1 MCRS1 CUL1 TCF20 SMC4 AMBRA1 CCT2 SIRT6 TRIM33 HMCN1 POLI CTNND1 | 6.46e-05 | 557 | 227 | 18 | int:DVL2 |
| Interaction | ELK3 interactions | 6.52e-05 | 120 | 227 | 8 | int:ELK3 | |
| Interaction | BRCA1 interactions | CDK9 NCOA3 ILK AIMP1 PABPC4 PSMD13 PGK1 GTF3C4 EMSY DDX1 NF1 ALMS1 UBR5 IFI30 MCRS1 TACC3 MOV10 KIF23 RBM45 CCT2 MAU2 PABPC1 TRIM33 ARNT GTF2H4 RNF6 MTOR TKT TP63 CNOT1 | 7.27e-05 | 1249 | 227 | 30 | int:BRCA1 |
| Interaction | PAIP2 interactions | 7.60e-05 | 63 | 227 | 6 | int:PAIP2 | |
| Interaction | KLF5 interactions | 7.62e-05 | 195 | 227 | 10 | int:KLF5 | |
| Interaction | SOX10 interactions | 8.16e-05 | 92 | 227 | 7 | int:SOX10 | |
| Interaction | KLF4 interactions | 8.61e-05 | 160 | 227 | 9 | int:KLF4 | |
| Interaction | RERE interactions | 8.74e-05 | 93 | 227 | 7 | int:RERE | |
| Interaction | TNRC6B interactions | MKS1 AP2M1 ALMS1 HELZ PHIP MOV10 CUL1 KAT6A PABPC1 GIGYF2 USP54 CNOT1 | 9.02e-05 | 282 | 227 | 12 | int:TNRC6B |
| Interaction | WWTR1 interactions | NCOA6 MYCBP2 EMSY ALMS1 TACC3 KDM6A NOTCH1 CUL1 KIF23 TCF20 ARNT KMT2D TP63 CTNND1 CNOT1 | 9.40e-05 | 422 | 227 | 15 | int:WWTR1 |
| Interaction | IGBP1 interactions | 9.48e-05 | 162 | 227 | 9 | int:IGBP1 | |
| Interaction | TRIM37 interactions | TTLL5 PABPC4 TBC1D2 ALMS1 UBR5 MCRS1 MGA NOTCH1 KIF23 RARA LDLR TRIM33 NCOR2 KMT2D RNF6 MTOR BBS7 GIGYF2 SPEN | 1.01e-04 | 630 | 227 | 19 | int:TRIM37 |
| Interaction | ATXN2L interactions | CDK9 PABPC4 DDX1 AP2M1 UBR5 PHLPP1 KIF23 SIRT6 PAPSS2 PABPC1 CCNT1 GIGYF2 | 1.03e-04 | 286 | 227 | 12 | int:ATXN2L |
| Interaction | ZNRD2 interactions | MYO1D UBE4B CYTH2 HROB LRRC7 TACC3 MGA DNM2 SMC4 CCT2 TRIM33 TKT | 1.10e-04 | 288 | 227 | 12 | int:ZNRD2 |
| Interaction | SOX9 interactions | 1.14e-04 | 97 | 227 | 7 | int:SOX9 | |
| Interaction | KMT2B interactions | 1.14e-04 | 130 | 227 | 8 | int:KMT2B | |
| Interaction | SNW1 interactions | CDK9 DDX19B ILK PSMD13 DDX1 UBR5 PHLPP1 NOTCH1 DNM2 CUL1 RARA RBM45 SMC4 CCT2 MAU2 PABPC1 LDLR CCNT1 NCOR2 LRP2 CNOT1 | 1.16e-04 | 747 | 227 | 21 | int:SNW1 |
| Interaction | GCM1 interactions | 1.17e-04 | 68 | 227 | 6 | int:GCM1 | |
| Interaction | HNRNPD interactions | CDK9 NCOA3 ERG PABPC4 PGK1 DDX1 HIRA MED24 ALAS2 MOV10 DNM2 CUL1 FNDC3B RARA RBM45 PAPSS2 PABPC1 MTOR TP63 | 1.18e-04 | 638 | 227 | 19 | int:HNRNPD |
| Interaction | HDAC2 interactions | MYCBP2 PABPC4 DTX3L ZFPM1 EMSY DDX1 DMD KDM6A MOV10 CRTC3 RARA TCF20 SMC4 GRB10 MAU2 SIRT6 PAPSS2 PAPSS1 PABPC1 NCOR2 TP63 EHMT1 SPEN | 1.25e-04 | 865 | 227 | 23 | int:HDAC2 |
| Interaction | SETD1A interactions | 1.37e-04 | 170 | 227 | 9 | int:SETD1A | |
| Interaction | NFIC interactions | 1.40e-04 | 210 | 227 | 10 | int:NFIC | |
| Interaction | PML interactions | MYO1D DTX3L PGK1 GTF3C4 EMSY HIRA MED24 NF1 ZNF608 UBR5 PHIP DNM2 CUL1 RARA KAT6A SIRT6 TRIM33 CCNT1 NCOR2 ARNT MTOR TP63 PAXIP1 MYB | 1.46e-04 | 933 | 227 | 24 | int:PML |
| Interaction | TBP interactions | NCOA3 NCOA6 CAND2 GTF3C4 IFI30 WDR62 RARB POU2F2 TRIM33 GTF2H4 OIT3 | 1.47e-04 | 253 | 227 | 11 | int:TBP |
| Interaction | MYO1A interactions | 1.65e-04 | 25 | 227 | 4 | int:MYO1A | |
| Interaction | CCT8 interactions | CDK9 ILK AIMP1 PDK1 PDK3 PSMD13 STRADB FBXO25 PHLPP1 HCFC2 NOTCH1 CUL1 AMBRA1 CCT2 SIRT6 PABPC1 TP63 | 1.76e-04 | 550 | 227 | 17 | int:CCT8 |
| Interaction | RXRG interactions | 1.81e-04 | 47 | 227 | 5 | int:RXRG | |
| Interaction | PMS1 interactions | 1.87e-04 | 105 | 227 | 7 | int:PMS1 | |
| Interaction | DDX59 interactions | 1.93e-04 | 26 | 227 | 4 | int:DDX59 | |
| Interaction | SOX15 interactions | 2.01e-04 | 141 | 227 | 8 | int:SOX15 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.73e-06 | 25 | 165 | 5 | 775 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.62e-04 | 17 | 165 | 3 | 486 | |
| GeneFamily | Cyclins|P-TEFb complex | 4.91e-04 | 4 | 165 | 2 | 1281 | |
| GeneFamily | SINE class homeoboxes | 1.21e-03 | 6 | 165 | 2 | 525 | |
| GeneFamily | NLR family | 1.48e-03 | 25 | 165 | 3 | 666 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 6.75e-08 | 145 | 230 | 11 | M1810 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 BBX UBR5 PHLPP1 HELZ PHIP CUL1 KIF23 KAT6A SMC4 FRYL TP63 BICRAL SPEN VPS13B | 7.54e-08 | 300 | 230 | 15 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 MYCBP2 RPS6KA2 ZZEF1 WDR43 HIRA PTPN12 BBX UBR5 PHLPP1 HELZ DMD PHIP CUL1 KIF23 KAT6A FRYL LDLR TRIM33 KIFAP3 NCOR2 GIGYF2 BICRAL SPEN VPS13B | 1.63e-07 | 856 | 230 | 25 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 MYCBP2 WDR43 HIRA PTPN12 BBX UBR5 PHLPP1 HELZ PHIP CUL1 KIF23 KAT6A FRYL TRIM33 GIGYF2 SPEN | 8.94e-07 | 466 | 230 | 17 | M13522 |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP | UBE4B PDK1 PDK3 RPS6KA2 NOTCH1 KIF23 SMC4 ADGRL1 LDLR TKT MYB | 1.70e-06 | 200 | 230 | 11 | M3038 |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 1.03e-05 | 197 | 230 | 10 | M5853 | |
| Coexpression | WANG_LMO4_TARGETS_DN | PSG6 PDK3 DTX3L BBX UBR5 DMD EXOC6 PAPSS2 SPRYD7 RNF6 EHMT1 PAM CTNND1 | 2.03e-05 | 361 | 230 | 13 | M12674 |
| Coexpression | GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP | 2.51e-05 | 134 | 230 | 8 | M430 | |
| Coexpression | SAGIV_CD24_TARGETS_UP | 3.73e-05 | 22 | 230 | 4 | M4144 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 4.70e-05 | 189 | 230 | 9 | M3112 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 6.23e-05 | 196 | 230 | 9 | M4244 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 7.00e-05 | 199 | 230 | 9 | M3257 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 7.28e-05 | 200 | 230 | 9 | M5851 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN | 7.28e-05 | 200 | 230 | 9 | M8576 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP | 7.28e-05 | 200 | 230 | 9 | M3979 | |
| Coexpression | GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP | 7.28e-05 | 200 | 230 | 9 | M8764 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 7.28e-05 | 200 | 230 | 9 | M7776 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.14e-04 | 212 | 230 | 9 | M39221 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | NOL4 INHBA DACH1 RGS11 HSD11B1L ADCY2 HIRA QSOX2 PCLO ADGRL1 POU2F2 PAPSS2 TMED8 | 1.17e-04 | 429 | 230 | 13 | M45694 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NOL4 PDE7A MYCBP2 INPP4A TENM2 MAGI2 SCN1A LRRC7 KIF3C HCFC2 IGSF3 PCLO AFF3 LAMA5 ADGRL1 POU2F2 GRIK1 SIX3 KIFAP3 CELSR3 GPR137C IGSF9B EPHB1 | 1.21e-04 | 1106 | 230 | 23 | M39071 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | PDE7A ESRP1 DACH1 BMP6 ZNRF3 UBR5 SH3RF1 TCF20 GRB10 MAML2 IL17RD | 4.68e-09 | 188 | 232 | 11 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | MYO1D MAGI2 NF1 UBR5 DMD KDM6A FNDC3B AFF3 AMBRA1 MAML2 VPS13B | 8.47e-09 | 199 | 232 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.57e-08 | 187 | 232 | 10 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.52e-08 | 198 | 232 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.56e-07 | 168 | 232 | 9 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-07 | 188 | 232 | 9 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.54e-07 | 191 | 232 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 192 | 232 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | BAL-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 9.62e-07 | 145 | 232 | 8 | 3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-06 | 170 | 232 | 8 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.27e-06 | 177 | 232 | 8 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.27e-06 | 177 | 232 | 8 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 178 | 232 | 8 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 178 | 232 | 8 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 180 | 232 | 8 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 180 | 232 | 8 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 6.65e-06 | 188 | 232 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.91e-06 | 189 | 232 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 190 | 232 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 190 | 232 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.47e-06 | 191 | 232 | 8 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.47e-06 | 191 | 232 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.76e-06 | 192 | 232 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 7.76e-06 | 192 | 232 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.76e-06 | 192 | 232 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-06 | 193 | 232 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.37e-06 | 194 | 232 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 195 | 232 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 195 | 232 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.69e-06 | 195 | 232 | 8 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.89e-06 | 140 | 232 | 7 | 82b150e9e9962460a5cd6bef7ee04f28f5c05d1a | |
| ToppCell | facs-Skin-nan-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 196 | 232 | 8 | 81f9754567bbfa67edd304b9ef7b03e7bd9a3b52 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 196 | 232 | 8 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 196 | 232 | 8 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.71e-06 | 198 | 232 | 8 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.71e-06 | 198 | 232 | 8 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.71e-06 | 198 | 232 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.71e-06 | 198 | 232 | 8 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | 9.71e-06 | 198 | 232 | 8 | ae0a51e63e2751a6d9dc0c8a3852680949173523 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 199 | 232 | 8 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-05 | 144 | 232 | 7 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tshz2-Nrep_(Subiculum_and_Entorhinal_Cortex)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 56 | 232 | 5 | 17c37bdd1f9733c3823e98ed4d1cd0ca9db66e9c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tshz2-Nrep_(Subiculum_and_Entorhinal_Cortex)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 56 | 232 | 5 | 7b7aaa514a3e85250d6279e0770a9409c4b0b199 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.33e-05 | 149 | 232 | 7 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 154 | 232 | 7 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 154 | 232 | 7 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.80e-05 | 156 | 232 | 7 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 160 | 232 | 7 | 0fee84844733d36805e1df90ca09478169746708 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 160 | 232 | 7 | 5c68d6a76c59e3a7e668ae5471396478a55756ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 165 | 232 | 7 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | Ciliated_cells-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.58e-05 | 165 | 232 | 7 | 0ebdbbdb151fb797335013d5838af1c7bbc45b06 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 2.78e-05 | 167 | 232 | 7 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-05 | 168 | 232 | 7 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.89e-05 | 168 | 232 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 169 | 232 | 7 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-05 | 170 | 232 | 7 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 171 | 232 | 7 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 174 | 232 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 175 | 232 | 7 | 8fb1e5f6aa68274adf322401db8c7b80e8c554d7 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 175 | 232 | 7 | 3ed22ea41810e73c02db4f2d03745e4ce7e43bb1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.04e-05 | 177 | 232 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 177 | 232 | 7 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.18e-05 | 178 | 232 | 7 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.18e-05 | 178 | 232 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.49e-05 | 180 | 232 | 7 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 180 | 232 | 7 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 181 | 232 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 181 | 232 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.82e-05 | 182 | 232 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 4.82e-05 | 182 | 232 | 7 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Interneuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.96e-05 | 125 | 232 | 6 | eafc39072467e209c9fe3a4fa41cb09507a42e82 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.98e-05 | 183 | 232 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 183 | 232 | 7 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-05 | 183 | 232 | 7 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 183 | 232 | 7 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.16e-05 | 184 | 232 | 7 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.16e-05 | 184 | 232 | 7 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 184 | 232 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.34e-05 | 185 | 232 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.34e-05 | 185 | 232 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.34e-05 | 185 | 232 | 7 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.34e-05 | 185 | 232 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.52e-05 | 186 | 232 | 7 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 5.52e-05 | 186 | 232 | 7 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 5.52e-05 | 186 | 232 | 7 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.71e-05 | 187 | 232 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.71e-05 | 187 | 232 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.91e-05 | 188 | 232 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.91e-05 | 188 | 232 | 7 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 188 | 232 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.11e-05 | 189 | 232 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 6.11e-05 | 189 | 232 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 6.11e-05 | 189 | 232 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.32e-05 | 190 | 232 | 7 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.32e-05 | 190 | 232 | 7 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.32e-05 | 190 | 232 | 7 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.32e-05 | 190 | 232 | 7 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | UBE4B PDK2 INPP4A EMSY MET NOD1 HELZ WDR62 GRB10 LDLR SPRYD7 ARNT | 8.37e-07 | 198 | 229 | 12 | 2246_DN |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | INHBA PDK2 TTLL5 ZZEF1 NF1 KAT6A ADGRL1 SIX1 CAPN10 OVGP1 CELSR3 BICRAL | 9.32e-07 | 200 | 229 | 12 | 7007_UP |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | INPP4A TTLL5 TMEM212 NF1 DNM2 RARA NLRX1 AMBRA1 CAPN10 ARNT LRP2 | 4.83e-06 | 195 | 229 | 11 | 5399_DN |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | UBE4B PDK3 INPP4A TMEM212 DACH1 MET PHLPP1 MCRS1 SPRYD7 ARNT RNF6 | 5.07e-06 | 196 | 229 | 11 | 7029_DN |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.59e-06 | 198 | 229 | 11 | 7437_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | PDK2 INPP4A EMSY NOD1 NF1 PHLPP1 RARA SMC4 ADGRL1 SIRT6 LRP2 | 5.59e-06 | 198 | 229 | 11 | 5451_DN |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | MYO1D PDK2 INPP4A EMSY MET WDR62 ADGRL1 SIRT6 RNF6 MTOR BBS7 | 5.87e-06 | 199 | 229 | 11 | 1488_DN |
| Drug | VER-246608 | 9.89e-06 | 5 | 229 | 3 | ctd:C000602510 | |
| Drug | Juvenile hormone | 1.49e-05 | 79 | 229 | 7 | CID006439662 | |
| Drug | AC1L2E0P | CDK9 DDX19B NCOA3 NCOA6 MED24 RARA RARB KAT6A LDLR LGALS4 TRIM33 NCOR2 MYB | 1.52e-05 | 307 | 229 | 13 | CID000019390 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.73e-05 | 183 | 229 | 10 | 7498_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | RPS6KA2 TTLL5 TMEM212 DACH1 NF1 KIF3C LDLR CAPN10 TRIM33 LRP2 | 2.18e-05 | 188 | 229 | 10 | 4835_DN |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A | 2.61e-05 | 192 | 229 | 10 | 7155_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.61e-05 | 192 | 229 | 10 | 2123_UP | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.73e-05 | 193 | 229 | 10 | 1464_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A | 2.73e-05 | 193 | 229 | 10 | 3028_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.86e-05 | 194 | 229 | 10 | 3431_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.98e-05 | 195 | 229 | 10 | 1539_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 3.12e-05 | 196 | 229 | 10 | 4535_UP | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 229 | 10 | 5394_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | RPS6KA2 TTLL5 TMEM212 DACH1 FZD1 NF1 KAT6A SIRT6 CAPN10 CELSR3 | 3.12e-05 | 196 | 229 | 10 | 5409_DN |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 229 | 10 | 5533_UP | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.26e-05 | 197 | 229 | 10 | 2783_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.26e-05 | 197 | 229 | 10 | 6258_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 3.40e-05 | 198 | 229 | 10 | 1694_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 3.40e-05 | 198 | 229 | 10 | 3356_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.40e-05 | 198 | 229 | 10 | 3421_DN | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.40e-05 | 198 | 229 | 10 | 5405_DN | |
| Drug | premix | 3.43e-05 | 19 | 229 | 4 | CID000013836 | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | UBE4B FZD1 KIF3C HCFC2 KDM6A WDR62 DNM2 CRISPLD2 GRB10 BICRAL | 3.55e-05 | 199 | 229 | 10 | 6977_DN |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | PDK2 TTLL5 ADCY2 PDLIM3 SCN1A KDM6A POU2F2 NCOR2 ARNT VPS13B | 3.55e-05 | 199 | 229 | 10 | 5994_UP |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.55e-05 | 199 | 229 | 10 | 7336_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.70e-05 | 200 | 229 | 10 | 5403_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.70e-05 | 200 | 229 | 10 | 6996_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | MYO1D INPP4A TTLL5 TMEM212 FZD1 IGSF3 MICAL1 BICRA NLRX1 PAPSS2 | 3.70e-05 | 200 | 229 | 10 | 7156_UP |
| Drug | 2-naphthoic acid | 5.42e-05 | 8 | 229 | 3 | CID000007123 | |
| Drug | Ro 8-8717 | 1.01e-04 | 2 | 229 | 2 | CID006438148 | |
| Drug | tubacin | 1.01e-04 | 2 | 229 | 2 | ctd:C474316 | |
| Drug | adenosine 5'-phosphoselenate | 1.01e-04 | 2 | 229 | 2 | CID000440758 | |
| Drug | Tamibarotene | 1.01e-04 | 2 | 229 | 2 | DB04942 | |
| Drug | beta-methylene-APS | 1.01e-04 | 2 | 229 | 2 | CID000129324 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.07e-04 | 184 | 229 | 9 | 7295_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 189 | 229 | 9 | 1700_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.42e-04 | 191 | 229 | 9 | 5234_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.54e-04 | 193 | 229 | 9 | 4067_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.54e-04 | 193 | 229 | 9 | 5315_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.54e-04 | 193 | 229 | 9 | 3098_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 6878_UP | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 4572_DN | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 1146_UP | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 5384_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 3460_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 5342_UP | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 4107_DN | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 5313_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 6821_DN | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 3737_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 6310_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 3663_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 7054_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 4155_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 6545_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 2311_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 5288_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 7312_DN | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 7055_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4392_DN | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4551_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 5404_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 7345_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; HL60; HG-U133A | 1.73e-04 | 196 | 229 | 9 | 1999_UP | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 5528_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4984_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4970_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 3936_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 7470_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 5106_UP | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 3933_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 4836_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 1.80e-04 | 197 | 229 | 9 | 205_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 3639_UP | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 1.80e-04 | 197 | 229 | 9 | 362_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 7440_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 7264_UP | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 7146_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 6096_UP | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 2095_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 5543_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 7268_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; HL60; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 2340_UP | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 5266_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 1482_DN | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 6685_DN | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 6206_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 2634_UP | |
| Drug | sulfacetamide | 1.91e-04 | 53 | 229 | 5 | CID000005320 | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; HL60; HG-U133A | 1.94e-04 | 199 | 229 | 9 | 1780_UP | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 6822_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 1527_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 1502_DN | |
| Disease | Adenoid Cystic Carcinoma | 1.23e-05 | 100 | 226 | 7 | C0010606 | |
| Disease | Cerebral Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0750936 | |
| Disease | Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0004114 | |
| Disease | Grade I Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.74e-05 | 25 | 226 | 4 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 3.74e-05 | 25 | 226 | 4 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 4.39e-05 | 26 | 226 | 4 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 4.39e-05 | 26 | 226 | 4 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 4.39e-05 | 26 | 226 | 4 | C0334582 | |
| Disease | sexual dimorphism measurement | NCOA6 PABPC4 ZZEF1 SPTBN5 MED24 BMP6 HROB NF1 ZNF608 BTN1A1 TACC3 MGA PHIP QSOX2 CRISPLD2 FNDC3B RARA GRB10 FRYL LDLR NCOR2 STARD3NL | 4.60e-05 | 1106 | 226 | 22 | EFO_0021796 |
| Disease | Anaplastic astrocytoma | 5.12e-05 | 27 | 226 | 4 | C0334579 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.36e-05 | 53 | 226 | 5 | C1961099 | |
| Disease | Kabuki syndrome 1 | 5.84e-05 | 2 | 226 | 2 | cv:CN030661 | |
| Disease | diabetes mellitus, family history | 5.84e-05 | 2 | 226 | 2 | EFO_0000400, EFO_0000493 | |
| Disease | Kabuki syndrome (is_implicated_in) | 5.84e-05 | 2 | 226 | 2 | DOID:0060473 (is_implicated_in) | |
| Disease | KABUKI SYNDROME 1 | 5.84e-05 | 2 | 226 | 2 | 147920 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 5.94e-05 | 28 | 226 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NCOA3 NCOA6 DTX3L EMSY NF1 LRRC7 DMD NOTCH1 NLRP8 FNDC3B MICAL1 RARA RARB PABPC1 THOC5 KMT2D MTOR EHMT1 USP54 SPEN VPS13B | 8.77e-05 | 1074 | 226 | 21 | C0006142 |
| Disease | smoking status measurement | NOL4 PDE7A INHBA TBC1D2 DACH1 TENM2 ADCY2 MAGI2 MET ALMS1 MCRS1 DNAH8 CABP1 RARB TCF20 BICRA AFF3 GRIK1 BICRAL IGSF9B CPNE4 EPHB1 | 9.22e-05 | 1160 | 226 | 22 | EFO_0006527 |
| Disease | Profound Mental Retardation | 1.02e-04 | 139 | 226 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.02e-04 | 139 | 226 | 7 | C0025363 | |
| Disease | Mental deficiency | 1.02e-04 | 139 | 226 | 7 | C0917816 | |
| Disease | cervical cancer | 1.30e-04 | 34 | 226 | 4 | C4048328 | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 1.74e-04 | 3 | 226 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.88e-04 | 15 | 226 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.88e-04 | 15 | 226 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.88e-04 | 15 | 226 | 3 | C0154091 | |
| Disease | Intellectual Disability | INPP4A AP2M1 NF1 SCN1A PHIP WDR62 TCF20 AFF3 CAPN10 MTOR BBS7 LRP2 | 1.89e-04 | 447 | 226 | 12 | C3714756 |
| Disease | anorexia nervosa | 2.04e-04 | 70 | 226 | 5 | MONDO_0005351 | |
| Disease | Glioblastoma Multiforme | 2.19e-04 | 111 | 226 | 6 | C1621958 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.31e-04 | 16 | 226 | 3 | C0334634 | |
| Disease | creatinine measurement, glomerular filtration rate | 2.91e-04 | 117 | 226 | 6 | EFO_0004518, EFO_0005208 | |
| Disease | Carcinoma of bladder | 3.32e-04 | 18 | 226 | 3 | C0699885 | |
| Disease | Kabuki make-up syndrome | 3.47e-04 | 4 | 226 | 2 | C0796004 | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 3.47e-04 | 4 | 226 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 3.47e-04 | 4 | 226 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 3.47e-04 | 4 | 226 | 2 | C0149940 | |
| Disease | Lesion of Sciatic Nerve | 3.47e-04 | 4 | 226 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 3.47e-04 | 4 | 226 | 2 | C0242013 | |
| Disease | Headache, fasting blood insulin measurement | 3.47e-04 | 4 | 226 | 2 | EFO_0004466, HP_0002315 | |
| Disease | Colorectal Carcinoma | BMP6 NF1 MCRS1 DMD DNAH8 KDM6A PHIP NLRP8 RARB CAPN10 ARNT OVGP1 TP63 LRP2 BPIFB2 | 3.66e-04 | 702 | 226 | 15 | C0009402 |
| Disease | Giant Cell Glioblastoma | 4.76e-04 | 84 | 226 | 5 | C0334588 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | PDE7A DACH1 TENM2 MAGI2 MET ALMS1 HELZ CABP1 RARB TCF20 AFF3 GRIK1 BICRAL IGSF9B CPNE4 EPHB1 | 4.89e-04 | 801 | 226 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 5.33e-04 | 21 | 226 | 3 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Insulinogenic index measurement | 5.75e-04 | 5 | 226 | 2 | EFO_0009961 | |
| Disease | Malignant Cystosarcoma Phyllodes | 5.75e-04 | 5 | 226 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 5.75e-04 | 5 | 226 | 2 | C0010701 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 7.01e-04 | 23 | 226 | 3 | C1708353 | |
| Disease | creatinine measurement | INTU CAND2 PDE7A INPP4A DACH1 ADCY2 DDX1 PTPN12 ALMS1 QSOX2 RARB LAMA5 GRB10 LDLR CELSR3 LRP2 GIGYF2 CTNND1 | 7.03e-04 | 995 | 226 | 18 | EFO_0004518 |
| Disease | Bladder Neoplasm | 7.55e-04 | 140 | 226 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 7.84e-04 | 141 | 226 | 6 | C0005684 | |
| Disease | Drugs used in diabetes use measurement | 8.25e-04 | 255 | 226 | 8 | EFO_0009924 | |
| Disease | hemochromatosis (is_implicated_in) | 8.58e-04 | 6 | 226 | 2 | DOID:2352 (is_implicated_in) | |
| Disease | myelofibrosis (implicated_via_orthology) | 8.58e-04 | 6 | 226 | 2 | DOID:4971 (implicated_via_orthology) | |
| Disease | triacylglycerol 52:6 measurement | 9.00e-04 | 25 | 226 | 3 | EFO_0010418 | |
| Disease | chronic obstructive pulmonary disease | DCHS2 PABPC4 EMSY MED24 BMP6 BTN1A1 DNM2 FNDC3B RARB AFF3 PELI1 HMCN1 MAML2 FGD6 | 9.18e-04 | 688 | 226 | 14 | EFO_0000341 |
| Disease | Prostatic Neoplasms | NCOA3 ERG SLC39A1 TBC1D2 ZFAND5 MET MGA KDM6A KAT6A KMT2D LRP2 IL17RD SPEN | 1.00e-03 | 616 | 226 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 ERG SLC39A1 TBC1D2 ZFAND5 MET MGA KDM6A KAT6A KMT2D LRP2 IL17RD SPEN | 1.00e-03 | 616 | 226 | 13 | C0376358 |
| Disease | anemia (biomarker_via_orthology) | 1.20e-03 | 7 | 226 | 2 | DOID:2355 (biomarker_via_orthology) | |
| Disease | hepatocyte growth factor receptor measurement | 1.20e-03 | 7 | 226 | 2 | EFO_0008153 | |
| Disease | level of Sterol ester (27:1/22:6) in blood serum | 1.20e-03 | 7 | 226 | 2 | OBA_2045201 | |
| Disease | arabitol measurement | 1.20e-03 | 7 | 226 | 2 | EFO_0800148 | |
| Disease | worry measurement | 1.24e-03 | 154 | 226 | 6 | EFO_0009589 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.26e-03 | 28 | 226 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.26e-03 | 28 | 226 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 1.32e-03 | 156 | 226 | 6 | DOID:10283 (is_marker_for) | |
| Disease | alcohol use disorder measurement | 1.37e-03 | 214 | 226 | 7 | EFO_0009458 | |
| Disease | vital capacity | NCOA3 NCOA6 CAND2 INHBA ZZEF1 TENM2 TTC19 BMP6 QSOX2 MOV10 MICAL1 RARB TCF20 IQCH PCLO AFF3 SIX1 NCOR2 HMCN1 LRP2 | 1.40e-03 | 1236 | 226 | 20 | EFO_0004312 |
| Disease | treatment-resistant hypertension | 1.54e-03 | 109 | 226 | 5 | EFO_1002006 | |
| Disease | menstrual cycle measurement | 1.59e-03 | 8 | 226 | 2 | EFO_0007786 | |
| Disease | holoprosencephaly (is_implicated_in) | 1.59e-03 | 8 | 226 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Ciliopathies | 1.61e-03 | 110 | 226 | 5 | C4277690 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.96e-03 | 69 | 226 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | susceptibility to mononucleosis measurement | 1.96e-03 | 69 | 226 | 4 | EFO_0008403 | |
| Disease | Carcinoma, Granular Cell | 2.03e-03 | 116 | 226 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.03e-03 | 116 | 226 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.03e-03 | 116 | 226 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.03e-03 | 116 | 226 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.03e-03 | 116 | 226 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 2.03e-03 | 116 | 226 | 5 | C0001418 | |
| Disease | Uterine Cervical Neoplasm | 2.42e-03 | 35 | 226 | 3 | C0007873 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 2.52e-03 | 10 | 226 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.52e-03 | 10 | 226 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | 2-ketocaprylate measurement | 2.52e-03 | 10 | 226 | 2 | EFO_0800110 | |
| Disease | prostate adenocarcinoma (is_marker_for) | 2.52e-03 | 10 | 226 | 2 | DOID:2526 (is_marker_for) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.54e-03 | 74 | 226 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Squamous cell carcinoma | 2.71e-03 | 124 | 226 | 5 | C0007137 | |
| Disease | cocaine use | 3.07e-03 | 11 | 226 | 2 | C3496069 | |
| Disease | Congenital Abnormality | 3.07e-03 | 11 | 226 | 2 | C0000768 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.07e-03 | 11 | 226 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 3.07e-03 | 11 | 226 | 2 | EFO_0801871 | |
| Disease | Myoclonic Astatic Epilepsy | 3.07e-03 | 11 | 226 | 2 | C0393702 | |
| Disease | Glioblastoma | 3.21e-03 | 79 | 226 | 4 | C0017636 | |
| Disease | balding measurement | MYCBP2 AIMP1 BBX ZNRF3 TACC3 BICRA AFF3 PAPSS1 NCOR2 UTP25 MTOR PAM MAML2 MYB | 3.35e-03 | 792 | 226 | 14 | EFO_0007825 |
| Disease | alcohol consumption measurement | TENM2 WDR43 SPTBN5 MAGI2 NF1 ALMS1 ZNF608 MGA PCLO AFF3 POU2F2 SIX3 ZIC1 NCOR2 MTOR TKT BPIFB2 IGSF9B CPNE4 | 3.41e-03 | 1242 | 226 | 19 | EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TIVSIPQRIHQMAAN | 1146 | P51826 | |
| MLAQISRHSNPTQGA | 621 | P27540 | |
| GEHTRRSVENNMPIL | 106 | Q5RHP9 | |
| DHDRPMNTLTLTGQF | 501 | Q8IWZ6 | |
| RTVIDDSRQVGQPMH | 46 | Q9NZN9 | |
| DSRQVGQPMHIIIGN | 51 | Q9NZN9 | |
| AAMENVHRGQRSTPL | 906 | Q8WY36 | |
| SFQDLSPVIHRSMQG | 1116 | P0C0L5 | |
| VAALGSDPHISMQVQ | 141 | Q13410 | |
| LNRGTMGNHLLTNPV | 1176 | O94910 | |
| SGLVNHVPLEQMQNR | 191 | Q12904 | |
| NMTGFRLLNIDNPHV | 276 | P39086 | |
| ALQNSPRLMHARNTG | 211 | P11308 | |
| IQISDNHTLISMGRP | 2836 | Q8TCU4 | |
| QMRENHSPLPQGQDS | 2941 | Q8TCU4 | |
| MSQAIQPAHATARGE | 11 | Q8WYK0 | |
| ILGRSMQPGSDQNHF | 616 | P19021 | |
| RQNGMGIIESAPQEH | 301 | Q6NSI1 | |
| IDRPSIHSQEMLGQF | 646 | Q9HC96 | |
| VNMLHSLLSAQGVQP | 661 | O60563 | |
| SIIMLNTSLHNPNVR | 191 | Q9UIA0 | |
| NLMRHSEDNPNQIRI | 1311 | P11532 | |
| RSGTVSQEALHQDMP | 666 | Q9C0C7 | |
| QPEHRGVPLQSQTAM | 231 | Q7Z5J1 | |
| LIELSQQINMNLGGH | 266 | Q9NZU7 | |
| SSDRIPVHQNGLSMN | 526 | Q9UI36 | |
| LHGAQMSIISAQDLP | 161 | A6H8M9 | |
| LLQSMGVQLPDNTDH | 621 | O95905 | |
| ININERADNGSTPMH | 261 | Q8N9B4 | |
| LNHQGRPSGDAFIQM | 481 | Q6NXG1 | |
| EQSHRPFLMLQARQS | 286 | P08476 | |
| SNMRQEALGHEPRVN | 206 | Q8IUH3 | |
| TLNRTQMHNAGFGPL | 291 | P10276 | |
| VGQERLPQSSMPQQH | 606 | Q9H1K0 | |
| TLNRTQMHNAGFGPL | 291 | P10826 | |
| TMIDFLQNHTEGSRP | 171 | Q6ZRP7 | |
| EDLMIQHNCSRQGPT | 111 | Q6ZVN8 | |
| SRTMEQTLEGLRQPH | 371 | O94810 | |
| LFIIHQEISAPNMQG | 971 | Q86VS3 | |
| PTTDGNHLRILEQMA | 236 | Q96PE3 | |
| AVHVQGQEPLTASML | 536 | P11940 | |
| RNRHNDVIPTMAQGV | 146 | Q15118 | |
| HINPRMGNGTVVRNS | 236 | P56470 | |
| DIQQMNRPSNVAHIL | 346 | Q6ZW49 | |
| LNSIHSMRVQISQSP | 966 | P54762 | |
| MARQPNILVHLQTSA | 3061 | Q8WXI7 | |
| DALQQRPSVLHNTGM | 1866 | Q9Y618 | |
| VHVQGQEPLTASMLA | 546 | Q13310 | |
| RNPVHNGHALLMQDT | 411 | O95340 | |
| SVFLTALGPQNRTMH | 11 | Q8NGC7 | |
| IQDNMGRTPLHAAVS | 1956 | P46531 | |
| GVRMDPHRQGSNNIV | 411 | Q9Y5Z7 | |
| DAVVTLSQHPNIVGM | 181 | Q86XE5 | |
| KPRNLNISQHGSDMQ | 201 | Q8NFM7 | |
| LAVNGQSIINMPHAD | 976 | Q86UL8 | |
| PVSNTQLQGHRMVLQ | 1776 | Q8IWI9 | |
| SGMNLFRHPNGQIVQ | 1796 | Q8IWI9 | |
| HTSANLVMTPQGQLL | 2591 | Q8IWI9 | |
| TMNTTNQQLELHLGG | 281 | Q8NI17 | |
| MLNQDLIGVLTGNQH | 746 | Q86W28 | |
| MGSQSLQHRSREQQP | 1381 | Q96NW7 | |
| EAMLHLGIDTPTQNN | 281 | Q96H55 | |
| SVNTKPRIHMNGSRN | 1061 | Q8NDA2 | |
| RLNQNLAPAGMINSH | 326 | Q8N3F9 | |
| QQHQMRPTGVAQVRS | 506 | O15550 | |
| RMHNQIPQVTSDGKR | 386 | Q92499 | |
| LLIGGRNIMDHTNEQ | 521 | O14782 | |
| RPLSQHQEQIIQMNG | 4471 | Q9Y6V0 | |
| NLRNSPLEIMSRNHG | 371 | Q8WWZ8 | |
| INPATRAMGINNTHT | 56 | A0A087WWA1 | |
| HLPLESRQQMETQIG | 301 | Q13946 | |
| MLHNKLRGQVQPQAS | 61 | Q9H0B8 | |
| HNIENASPATVSRMG | 2246 | Q96JB1 | |
| SQRIQTAHPAGRQVM | 1291 | O94915 | |
| HDLQLLPQQAGMASI | 216 | Q8IX07 | |
| HLPQAQLMLTGSQLA | 86 | P09086 | |
| VHLNRMQPSSLVQRN | 431 | Q9Y239 | |
| PHQQSGRSLEDIMVS | 406 | Q8N3J3 | |
| QLLSQTSPENMHRNV | 441 | Q8TDZ2 | |
| SHDNRTAQIMQLPPG | 576 | A0A1B0GV03 | |
| QVNNGLTLSDLPLHM | 221 | Q8TCJ0 | |
| PARCMIVHQGTILDN | 371 | P10242 | |
| TMVPVAGQGRNALHV | 2086 | P98164 | |
| VNLLMSPQGQVLSAH | 181 | Q96CW1 | |
| RAHSSMVGVNLPQKA | 171 | P00558 | |
| MLNNLPGVTSVHSRF | 141 | Q9UNM6 | |
| PAIHEQLRGINASSM | 2186 | O15230 | |
| SATPAQRDHLVQMLS | 341 | Q86UT6 | |
| AGHVSPLINVLMANV | 266 | Q8NGJ7 | |
| MAQDFSQHPQTGIIR | 1 | Q9P1G2 | |
| RMGTPHLQKTLNQQL | 271 | P50570 | |
| ATQNTRIVLAGDHMQ | 811 | P42694 | |
| LVLQPQSNMHETVDG | 316 | Q8TAG9 | |
| GMSRHPQVLQATQET | 201 | P22557 | |
| NRHNDVVPTMAQGVL | 121 | Q15119 | |
| DQAQGRMPFLVETLH | 5046 | Q96RW7 | |
| TQMLQTQAHPLGPQR | 1101 | Q6V1P9 | |
| EGIQQSGLNTPHIIM | 296 | Q9ULD6 | |
| GNSQQLRPNLTHSMA | 931 | Q8IZL2 | |
| AMDPLLSGLHIQQQS | 216 | Q14686 | |
| NMSATNIGIPHTQRL | 1831 | Q92794 | |
| RNPVHNGHALLMQDT | 421 | O43252 | |
| RPFRQNTHGIQMTSI | 376 | Q9H3D4 | |
| APDMSPQRISNQLHG | 206 | Q8NC74 | |
| QTIMPNLLGHTNQED | 131 | Q9UP38 | |
| TDVPMGQHNFQNRTL | 526 | Q08462 | |
| LQTTAMPQTLHRVEQ | 146 | O75054 | |
| GPHMSVNIVNQQNTR | 356 | Q6AI39 | |
| PMLNNQNTAVHLVSG | 461 | Q6AI39 | |
| INRTVIGMNRQSPHI | 936 | Q9H7D0 | |
| QMLHALNTANNLDVP | 1141 | Q6Y7W6 | |
| NQESMTLTGLPNHLA | 486 | Q8TDB6 | |
| QLMHANAQRTDALQP | 186 | P13284 | |
| FQAHIQASQGIMQPL | 876 | Q92562 | |
| VNNIPAAMTHLGIRS | 306 | Q6UUV7 | |
| MSSTRSQNPHGLKQI | 1 | Q13616 | |
| MPHLVNGDAAQQVIL | 26 | Q53EP0 | |
| QLVHRTEVVMNNLSP | 191 | Q96A23 | |
| AVIMLNTSLHNPNVR | 191 | Q99418 | |
| QGHQDQSIRIQRMLP | 251 | Q9UMR2 | |
| IQSHNPLARNIMQTA | 556 | Q86WZ0 | |
| NVMNRGDDTPLHLAA | 61 | Q13418 | |
| QNLMVSHPLRQRSVS | 1466 | Q86UU0 | |
| PQHNMGLQLSVVTRD | 321 | P22004 | |
| TMNPENEQHRLGSGL | 151 | A2IDD5 | |
| SRHQLVGGNLVIMNP | 86 | Q02246 | |
| AMRQLHPEAIAAIQS | 191 | Q96EZ8 | |
| INQTNGHPRCMSVIV | 146 | Q86Y78 | |
| SMQSDTVPLLQNGQH | 71 | Q13322 | |
| ASSPGAITHIMQQAL | 891 | Q7Z589 | |
| MRISGLSHTQPTQIE | 2466 | Q8NDH2 | |
| NHSQGPLRSMVEDLQ | 396 | Q03111 | |
| QHAQALGMPLTTQQA | 1366 | A6NE01 | |
| HAMNNSGPTAQIIER | 241 | P54198 | |
| QILLTQHGIPVMNLS | 826 | P54198 | |
| RATQGVLMQVQAGPH | 1796 | Q9NYQ7 | |
| HQAMVEQLTGQQTPR | 171 | Q6ZN32 | |
| EVANGLRNPVSMVHA | 211 | Q6UWX4 | |
| LLNQGSSIVIPAQHM | 451 | Q9NZM4 | |
| TQTGSNLHMLRGQVP | 421 | O75155 | |
| SPIMQGNTEQHQLAL | 226 | P50750 | |
| QMQDIPINPRDHLSS | 576 | Q9UNA4 | |
| VMVGVHQRPENSTQL | 96 | E5RG02 | |
| VAILGLPILNMANHN | 21 | Q8TCC7 | |
| LMHNENLNGVPSITN | 206 | Q9UKG4 | |
| VLGNHRESNNMVVPA | 511 | Q9Y6X3 | |
| VTSPMNIDRNITHLQ | 1046 | Q9H9B1 | |
| VHSEVLMPNRGNTQV | 406 | Q68DL7 | |
| LMPNRGNTQVQHTNL | 411 | Q68DL7 | |
| ANPLMANGTLTRRHQ | 51 | O60716 | |
| GTVQSAALMATHQPL | 421 | Q9UJU5 | |
| MIRNISQHDGPTKNL | 486 | Q92845 | |
| NLTSEVGTHPRMGNL | 596 | Q12889 | |
| HQATQTRELLQPMVS | 206 | A6NGG8 | |
| DGLTTNGVLVMHPRN | 181 | Q96FA3 | |
| GQQLMSQPQLHRRSN | 701 | Q02241 | |
| EQSARMLGHLVSNAP | 751 | P42345 | |
| RNGKTPLMVAVLNNH | 276 | Q8TC84 | |
| NLNSVSVPRMVINVH | 766 | P08581 | |
| SVPRMVINVHEAGRN | 771 | P08581 | |
| QVAVRNVPMTGSISH | 556 | Q68CQ4 | |
| QAHQMRLAQNAARIP | 586 | Q9UPN9 | |
| NHLVAGRAMTLSPQE | 306 | Q9Y6A5 | |
| LLEQENHSPLTGSNM | 721 | Q9H5Y7 | |
| QQQTMARHLTEILGE | 391 | Q9BRC7 | |
| SLESNPEQLQAMRHI | 496 | Q9HCE1 | |
| PEQLQAMRHIVTGTT | 501 | Q9HCE1 | |
| LNGQNLPMTHRLQLS | 181 | Q00889 | |
| SQLHTVNMRDPLNRV | 886 | O75448 | |
| SMEQVSHGTQNRPLL | 1016 | Q9Y6Q9 | |
| IQRVQAMKSPDHNGE | 11 | Q05209 | |
| LQRNGQHLPDMHSEL | 506 | Q9Y252 | |
| AKNRLQHQAIGPSGM | 266 | O95343 | |
| QHQAIGPSGMRSLAE | 271 | O95343 | |
| PDQNSVLLLQGNMGH | 226 | Q15475 | |
| LMAHAVTQLANRTPG | 416 | P78371 | |
| TENHQVSIIAGRPMH | 1441 | Q9NT68 | |
| NHNTLQTLKSDGRMP | 2791 | O75592 | |
| MLHDNRNEPTQPRQS | 236 | Q53GG5 | |
| QDSLMTAVRPALQHV | 26 | O00623 | |
| PTQTHMALVQLERVG | 91 | Q8N6T7 | |
| RNRHNDVVPTMAQGV | 116 | Q15120 | |
| VNLNQIPLGRDMHSL | 86 | Q5W111 | |
| NLEERMQSPQNLHGQ | 241 | O94818 | |
| MQHNREADGSLQPLP | 246 | Q5JTZ9 | |
| GHSAGPMVRQRQQDL | 1801 | Q9NRC6 | |
| PMTDHFNNVLTVGNL | 791 | P35498 | |
| MAGSTDQIAHLRPQT | 431 | Q7Z6J0 | |
| MRHQQTERQDPSQPL | 1 | Q9H853 | |
| GATPVAMLHTNNATL | 321 | Q8N4F0 | |
| EQQHNPAANPTMIRA | 1916 | A5YKK6 | |
| MESTPSRGLNRVHLQ | 1 | Q92759 | |
| LVTSQLPQAMGTRHT | 301 | Q5VZI3 | |
| QGERHPQTIVLMSDL | 271 | Q6DKK2 | |
| AGLSNAGVMQNPRHL | 16 | A0A087X0M5 | |
| QLPGHEAATLRNMNQ | 11 | Q9Y330 | |
| EHLQRQQNSGRMSPM | 36 | O76080 | |
| SARLIQNGHINMQLP | 171 | A6NML5 | |
| VRNNHVINTPLQTMH | 191 | Q9NXB0 | |
| SHLSQGEVRMNTPTL | 3091 | Q96T58 | |
| EGVRQMHSNAPRSEI | 696 | Q8WWQ0 | |
| RLGQSDPAPLQHQMD | 186 | P29401 | |
| MQPLVSQGQLRHTSQ | 1126 | Q9UPX0 | |
| PLHQLAQSVLEGMAA | 266 | Q9NY26 | |
| GNQVEHPQMTFGRLQ | 91 | O60225 | |
| SLRNIHSINPTQLMA | 21 | O95772 | |
| LENMPLSHSRTQGAQ | 6 | Q9UNG2 | |
| QSLGLNVHNMTPATS | 51 | O95155 | |
| QMHPGTGQARREQQI | 171 | A6NJL1 | |
| HLQSGRNLGVSAPQM | 466 | Q6ZV73 | |
| QELHTPTQGQTMVRQ | 81 | Q8IV45 | |
| LTIANQGTPLTFMHQ | 1801 | P21359 | |
| EAGAPRLMITHIVNQ | 76 | Q9NTJ3 | |
| MLRLPGQEDHSSQNP | 1236 | Q9UGU0 | |
| GQEDHSSQNPLIMRR | 1241 | Q9UGU0 | |
| IITTEGMINGLHPVN | 491 | Q9UKN8 | |
| IENGVNMQHFLTIPR | 481 | Q7Z4N2 | |
| RVMQVSPDGQHLASG | 496 | O43379 | |
| PTGIHILVSDQMVQN | 501 | Q9NZI7 | |
| AGHASPNVVNGQMRL | 151 | Q15915 | |
| ALLHTSQQPVGEAMV | 566 | Q96MP5 | |
| MAPLHVLTQNGAESS | 916 | Q9ULD9 | |
| LHQLIVANMTGLEPS | 1746 | Q7Z7G8 | |
| PLMFQVVISNAGHLN | 2116 | O43149 | |
| GNPVTLLTMDRHGEQ | 391 | Q9ULT6 | |
| LRSVPAAVGVMHNLQ | 726 | O60346 | |
| LASGQVPFQDMHRTQ | 261 | Q9C0K7 | |
| QEVTMRCQPILGHNT | 36 | A0A1B0GX78 | |
| SQPRQQLCGHAMVVT | 136 | Q8NA23 | |
| RIHFGQITSNQMLVP | 861 | Q9UNX4 | |
| AEVTMGDPHQQTLAR | 176 | Q13769 | |
| QHQRMHTGRNPISVT | 556 | Q5CZA5 | |
| RASNNLQHSLRMVLP | 721 | Q6EMB2 | |
| LGTEIQNTMHNIRGN | 211 | Q9BYX2 | |
| PQRSGDIVMIQSEHT | 116 | Q6PL24 | |
| MGVHSLINLPANSTI | 846 | O95071 | |
| KRLQGHPNSAVLMVQ | 511 | Q15061 | |
| TVSNMIHNRPSLASQ | 511 | Q70EL1 | |
| ALLNNPVHQSVTMGE | 211 | Q8TEU8 | |
| QGPHRQVLMTQSRVL | 3821 | O14686 | |
| DMVLFHNLTQPRGVN | 651 | P01130 | |
| MAPEVVNRRGHTQSA | 226 | Q15349 | |
| QLLQGGSEQMLRSLH | 206 | O94832 | |
| RNLHQSGAVQTMEPL | 1726 | Q9ULV0 |